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Sickle cell disease (SCD) is a genetically inherited blood disorder characterized by a
single point mutation that produces hemoglobin S within red blood cells (RBCs). When
such RBCs are deoxygenated hemoglobin S polymerizes and causes the cells to take on
a sickle shape and become more viscous and stiffer than normal RBCs. The hallmark of
SCD is painful vaso-occlusive crises in which the flow of blood to parts of the body is
obstructed. Today, millions of people suffer from SCD around the world and life
expectancy of individuals with SCD is in the 40’s. We developed several techniques to
facilitate and expedite experimental investigation of SCD and in general blood
biomechanics.

Vaso-occlusion is the result of interactions between blood cells and the endothelium.
Atomic force microscopy (AFM) has been employed in single-molecule force
spectroscopy (SMFM) and single-cell force spectroscopy (SCFS) assays to study these
interactions. In order to process results from these assays quickly, we developed
MATLAB-based custom software that expedited manual processing efforts from 1 to 2
hours to 10 to 15 minutes per experiment.

We explored microfluidic principles in order to further increase the throughput of the
number of cells we can study. We have designed an experimental setup that implements
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aspiration based assembly for microchannels which enables the use of most
functionalization techniques, and a pressure controller that allows instant and precise
changes in the microchannel flow. Utilizing this setup, we have quantified SS-RBC
adhesion to the integrin αvβ3, a specific adhesion protein expressed on the endothelium
which has been implicated in vaso-occlusion, and measured the shear modulus and
viscosity of the SS-RBC membrane.

We have designed a portable, swift, easy-to-use, small sample, and sterilization-free
rheometer capable of measuring the viscosity of Non-Newtonian liquids. This rheometer
can quickly measure the viscosity of body fluids such as whole blood and blood plasma,
which has been hypothesized to be of value in the assessment of SCD.

We explored expediting the development and review of simulations and threedimensional data. To this end, we have developed a virtual reality environment for
interactive multiphysics simulation and data visualization utilizing modern head-mounted
displays.
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Chapter 1: Introduction
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Sickle cell disease (SCD) is a genetically inherited blood disorder characterized by a
single point mutation. This mutation results in the replacement of the adult hemoglobin in
red blood cells by hemoglobin S (HbS). When red blood cells are deoxygenated HbS
polymerizes and causes the cells to take on a sickle shape and a rigid structure. As a
result, the hallmark of SCD is painful vaso-occlusive crises in which blood flow to parts of
the body is obstructed [1]. Vaso-occlusion is the result of interactions between blood cells
and the endothelium [2-4]. Today, millions of people suffer from sickle cell disease around
the world and life expectancy of individuals with sickle cell disease is in the 40’s [5, 6].
There is currently no drug available for patients of sickle cell disease that targets the
pathophysiology of the disease [7].

It has been shown that the adhesive behavior and viscoelastic response of sickle cell red
blood cells (SS-RBCs) are important factors in vaso-occlusion [8]. SS-RBC adhesion to
specific proteins, such as human integrin 𝛼𝑣 𝛽3 and laminin, expressed on the endothelium
has been implicated as part of the mechanism that triggers vaso-occlusive crises [2, 912] . During a vaso-occlusive crisis adherent SS-RBCs in the vasculature obstruct other
SS-RBCs due to their viscoelastic and mechanical properties [13, 14].

A number of experimental tools have been used to quantify SS-RBC specific adhesion to
proteins expressed on the endothelium. To this end, atomic force microscopy (AFM) has
been employed in single-molecule force spectroscopy (SMFM) and single-cell force
spectroscopy (SCFS) assays [10, 15-17]. Briefly, an atomic force microscope is capable
of measuring a wide range forces (5 pN to 106 pN) applied on a cantilever probe by
recording the deflection of the cantilever [18, 19]. Through the use of a controlled vertical
2

displacement applied to the probe by piezoelectric actuators the technique can produce
force-displacement signals during both the approach and the retraction of the probe
toward a cell. When the cantilever probe is functionalized with a specific ligand, the bond
strength of the ligand and its receptor can be measured on the retraction forcedisplacement curve [17]. Significant data processing and additional experimentation was
necessary of our publication using single-cell force spectroscopy studying the BCAM/Lu
and laminin specific adhesion [16]. In particular, we reprocessed the entirety of the SMFS
experimental data to ensure that each adhesion measurement represented specific
binding with an RBC. We distinguished these sites from erroneous data points by
identifying an effective spring constant of the adhesion complex and ensuring that we
processed data in which this constant was less that 10 pn/nm. We measured this spring
constant as the slope of the retraction curve after the cantilever retracted past the cell
surface and before adhesion complex was broken. We also performed experiments to
evaluate cell stiffness which was calculated by probing red blood cells (RBCs) with an
AFM cantilever and curve fitting a theoretical model derived from the Hertz model to the
force-displacement response curves.

In order to process these results quickly, we developed MATLAB-based custom software
that expedited manual processing efforts from 1 to 2 hours per experiment to 10 to 15
minutes per experiment. The MATLAB-based data processing tools developed as part of
this project were later published as FRAME, the Force Review Automation Environment
[22].

3

We sought to further increase the throughput of the number of cells we could reasonably
study and explored microfluidic principles to accomplish this. Typical microfluidic assays,
which aim at quantifying mechanical properties of sickle cell red blood cells (SS-RBCs),
suffer from a number of drawbacks in functionalization and flow control. Specifically,
physical adsorption functionalization techniques produce inconsistent functional surfaces,
and common volumetric flow pumps cannot be used to adjust the flow inside
microchannels with minimal delay. We have designed an experimental setup that
alleviates these complications by implementing aspiration for microchannel assembly that
enables the use of most functionalization techniques and a pressure controller that allows
instant and precise changes in the microchannel flow. Utilizing this setup, we have
quantified SS-RBC adhesion to the integrin αvβ3, a specific adhesion protein expressed
on the endothelium, as well as measured the shear modulus and viscosity of the SS-RBC
plasma membrane.

We explored expediting the development and review of simulations and three dimensional
data in sickle cell disease. To this end, we employed virtual reality. The recent commercial
success of virtual reality based on head-mounted display (HMD) technology has the
potential to fundamentally enhance the way we create, review, and interact with
simulations and three-dimensional data. Representation of such data and simulations in
virtual reality grants users the ability to explore them intuitively and personally. To this
end, we have developed a virtual reality environment for interactive multiphysics
simulation and data visualization. This environment integrates the visual fidelity, coding
standards, and affordability of modern HMDs with (1) manual and immersive threedimensional particle steering during simulation run-time and with (2) undistorted
4

volumetric rendering of static volumetric maps such as those produced by confocal
microscopy. This method of visualization provides a deeper understanding of such data
structures than previously explored methods, such as three dimensional anaglyph
stereoscopy.

We encountered the hypothesis that leg ulcerations and vaso-occlusive episodes in sickle
cell disease were related to whole blood viscosity. Unfortunately, current blood viscosity
measurement techniques are inadequate for large scale measurements. In particular,
commercially available rheometers are typically cumbersome, slow, necessitate constant
cleaning, and are priced in the tens of thousands of dollars at the most affordable. Such
devices are particularly inconvenient for clinical laboratory and point-of-care use because
of the large amount of fluid needed and because of sterilization requirements before and
after use.

Engineering, whether mechanical or not, is defined first and foremost by its key
constituent: synthesis. It is in this spirit of synthesis that we designed a portable, swift,
easy-to-use, small sample, sterilization-free, and cost-effective rheometer capable of
measuring the viscosity of both Newtonian and Non-Newtonian liquids. This rheometer
can quickly measure the viscosity of body fluids such as whole blood, blood plasma and
urine which have been found to be important in cardiovascular health assessment and
cognitive function evaluation as well as an important marker in certain diseases, such as
Alzheimer’s disease, dementia, myeloma, rheumatoid arthritis, and Waldenström’s
Macroglobulinemia as well as explore the aforementioned hypothesis in sickle cell
disease. This device will also quantify the viscosity of liquids such as inks, bioprinting
5

inks, and oils, where viscosity is crucial during formulation, quality assurance, and, in the
case of bioprinting inks, in regular use. An assembly based on this technique could
produce a device that is fast (1-5 minutes), portable, easy to use, requires only a drop of
the liquid (no more than 50 microliters), and does not need regular cleaning and
sterilization thanks to the use of a disposable microchannel cartridge.

6

Chapter 2: FRAME (Force Review Automation Environment):
MATLAB-based AFM data processor

7

2.1 Introduction
An atomic force microscope (AFM) is capable of measuring a wide range forces (5 pN to 106 pN)
applied on a cantilever probe by recording the deflection of the cantilever [27, 62]. Controlled
vertical displacement is applied to the probe by piezoelectric actuators in order to produce forcedisplacement curves. Atomic force microscopy has several applications. In particular, resultant
force-displacement curves have been used to measure the elastic modulus of biological samples
[63] and the unbinding force between specific receptor-ligand bonds [27]. Manually processing
these data requires researchers to separately review each measurement. This is very time
consuming and susceptible to user error or bias. Few free software applications for automatic
processing of AFM force measurements have been developed, and only two such programs have
seen some use [64, 65]. OpenFovea processes unbinding measurements by curve-fitting either
the Worm Like Chain (WLC) or the Freely Jointed Chain (FJC) models in order to identify unbinding
events, while Hooke uses a fuzzy logic algorithm to identify unbinding events based on
conformity with specific, pre-defined, characteristics. However, in AFM experiments that probe
cellular surfaces directly, and in single cell force spectroscopy (SCFS) experiments, both
aforementioned methods cannot be implemented since cellular surface deformation and
multiple simultaneous ligand-receptor bonds alter the force-displacement curve shape [16, 53].
As a result, most AFM data are still manually processed, and no clear standard has emerged in
the automated processing of both Young’s moduli and ligand-receptor unbinding measurements.

We have created an open-source software application based on MATLAB, the force review
automation environment or FRAME, to greatly increase the speed at which AFM data are

8

Figure 2-1. Comparison of data processed manually and using FRAME. (a) FRAME
displays the contact fit (dashed black line) used to compute a sample’s Young’s
modulus, the contact point (black circle) and the end of fit point (green circle) based on
the force-displacement curve (red and blue line plots). (b) Box-whisker plots showing
the results of Young’s modulus measurements on Human Embryonic Kidney
(HEK293T) cells as processed from the same data set manually and using FRAME.
The two results do not pass the test of significant difference (nonparametric MannWhitney test, p>0.8). (c) Histograms showing the results of Young’s modulus
9

measurements on HEK293T cells as processed from the same data set manually and
using FRAME. (d) FRAME detection of an unbinding event (purple line plot noted by
arrow) between αvβ3 and ICAM4 receptor expressed on the surface of a red blood cell
(SS-RBC) from a patient with sickle cell disease (SCD) and an approximation of the
curve behavior before the unbinding event (teal line plot) on a force-displacement curve
(red and blue line plots). (e) Box-whisker plots of unbinding forces between αvβ3
attached on a cantilever tip and ICAM4 receptor expressed on the surface of a SSRBC. When processed manually and using FRAME, the results show no significant
difference (nonparametric Mann-Whitney test, p>0.84). (f) Histograms of unbinding
forces between αvβ3 attached on a cantilever tip and ICAM4 receptor expressed on the
surface of a SS-RBC as processed manually and using FRAME.
processed. FRAME is intuitive and easy to operate, even for the novice MATLAB user. It features
a number of algorithms to streamline automated processing and a graphic user interface (GUI)
to expedite manual processing and review of the data. Even if FRAME is only used in manual
mode it can greatly accelerate data processing, especially for large sets of data. The results can
be displayed in FRAME with MATLAB plotting tools, as well as exported as a Microsoft Excel file,
for further statistical analysis. FRAME, the User Manual, and a demonstration video can be found
online

at

the

Cellular

Mechanics

Laboratory

webpage

(http://www.engr.uconn.edu/~gelyko/frame.html). FRAME is shared both as a Windows
executable and as MATLAB code under the open-source BSD license.

2.2 Methods
FRAME can be used to compute Young's moduli and ligand-receptor unbinding forces.
In particular, the Hertz contact model for spherical and pyramid shape cantilever tip has
been implemented [66, 67]. Manual processing of data produced in a contact experiment
requires the user to identify, on the force-displacement curve, the point where the
cantilever tip comes in contact with the sample's surface. FRAME uses a least-squares
minimization for the curve-fit of the Hertz contact model to identify both the Young’s
10

modulus of the sample and the contact point on the curve. Before any force-displacement
curve is fit with a contact model, it is first “flattened,” a process in which the curve’s force
response before contact with the sample is defined to have an average force value of
zero. In order to curve-fit the extension portion of force-displacement curves to the contact
model and locate the contact point, FRAME effectively uses a least-squares minimization
of the following expression: 𝐹(𝑧) = 𝑔(𝑧 − 𝑧1 ) ∗ [𝐻(𝑧 − 𝑧1 ) − 𝐻(𝑧 − 𝑧2 )]. In this expression
𝑧 is the vertical displacement, 𝐹(𝑧) is the force detected by the cantilever, 𝐻 is the
Heaviside function, 𝑔(𝑧) represents the contact model, 𝑧1 is the contact point and a design
variable, and 𝑧2 is the end the curve-fit range which can be either defined by the user or
be a design variable. The initial conditions for the minimization are determined from the
flattening process (see supplementary information). Other contact models can be easily
implemented by the user through a simple guided modification of the MATLAB script. The
step by step instructions for using custom contact models can be found in the user
manual. The quality of the curve-fit, based on the root-mean-squared of the curve-fit
residuals, can also be employed to ignore low quality curves from data sets. FRAME also
provides users with the tools to manually identify the contact point and the curve-fit range
on individual curves while retaining automated processing functionality on all others.

In addition, FRAME provides users with a set of algorithms to detect and quantify ligandreceptor unbinding events based on a number of user provided parameters. Potential
unbinding events are selected by the algorithms based on force thresholds provided by
the user. The unbinding event detection algorithms verify that high amplitude noise is not
misinterpreted as an unbinding event by confirming that the abrupt curve shift at the
location of a possible unbinding event is permanent. FRAME can fit the curve before an
11

unbinding event to the WLC model and produce the persistence and contour lengths
associated with this event. Because the software treats each unbinding event on an
individual basis and because users may alter many relevant parameters for unbinding
event detection, these algorithms are applicable to any force range. FRAME is equipped
with several functions and a user friendly GUI that allow users to very quickly review
preliminary results and modify parameters based on a few representative curves per set
of data in order to assure consistent performance. Users also have access to tools that
allow them to manually select unbinding events on individual curves while retaining
automated processing functionality on all others.

2.3 Results
We compared results derived from manual and automatic processing of data collected in
receptor-ligand unbinding and in elasticity experiments.

2.3.1 Young’s Modulus Measurements
Measurements of the Young’s modulus of four Human Embryonic Kidney (HEK293T)
cells were automatically and manually processed (see Supplementary information). The
parameters for FRAME automated processing were chosen with regard to representative
curves and the set of data was automatically processed using these parameters. We did
not observe a statistically significant difference between manually processed and FRAME
processed results (see Figure 2-1b). Based on these findings it is confirmed that the
proposed automated method generates results consistent with manually processed
results.
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Figure 2-2. The FRAME graphical user interface (GUI) during typical use for unbinding
event detection. All options, parameters, tools, and plots of force-displacement curves
are available on one window.

2.3.2 Unbinding Events Measurements
Unbinding-force measurements were taken between the ICAM4 receptor expressed on
the surface of a sickle human red blood cell (SS-RBCs) and a probe functionalized with
the integrin αvβ3 and manually processed (see Supplementary information). The
parameters for FRAME automated unbinding event detection were set with regards to
representative curves. The curves were automatically processed using these parameters.
We did not observe a statistically significant difference between manually processed and
automatically processed results (see Figure 2-1e)
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2.4 Discussion
FRAME offers a directly applicable array of modifiable tools to AFM users for expediting
data processing. The software processes AFM data extremely quickly compared to the
time required for manual processing. 1024 curves are processed in less than one minute
for unbinding events and in less than five minutes for Young's modulus measurements in
a work station with an Intel® Core™ 2 Duo CPU at 3.00 GHz and 8.00 GB of installed
memory (RAM). FRAME also provides convenient manual processing tools that are
integrated with automated processing. The GUI is intuitive and easy to use, requiring little
to no user training. FRAME can automatically import force-displacement curves from
AFMs by Asylum Research (.ibw files). Users of other brands of AFMs can import forcedisplacement measurements formatted as delimited text files into FRAME following
instructions in the User's Manual.

2.5 Supplementary Information
2.5.1 Cell Culture and Preparation
Human Embryonic Kidney (HEK293T) cells were plated on poly-L-lysine coated glass
bottom petri dishes in solution containing Dulbecco’s Modified Eagle media, 10% fetal
bovine serum, and 1% Penicillin-Streptomycin.

Heparin-anticoagulated venous blood was drawn from patients with sickle cell disease
with the approval of the Institutional Review Boards of the UCONN Health Center and
UCONN-Storrs. The whole blood, containing sickle cell human red blood cells (SSRBCs), was centrifuged at 500 g for 10 minutes at 4°C to isolate the cells and discard the
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buffy coat and plasma. The SS-RBCs were washed three times with Alsever’s solution
and stored in Alsever’s solution. SS-RBCs were immobilized by incubation for 10 minutes
at 37°C on a poly-L-lysine coated glass bottom petri dish. Excess and unattached SSRBCs were washed away by rinsing.

Supplementary Figure 2-S1. The effects of varying the slope ratio 𝒃 in the FRAME
stiffness algorithm on two hundred curves. (a) The detected contact point on individual
curves does no change more than 60nm from the average measurement as the slope
ratio 𝒃 is varied. (b) The corresponding Young’s Moduli are not significantly different
from one another as the slope ratio 𝒃 is varied (nonparametric Kruskal-Wallis test,
p>0.8).

2.5.2 Probe Functionalization
Silicon nitride cantilever probes (Bruker Probes, Camarillo, CA) were silanized with 2%
v/v 3-aminopropyltriethoxysilane in acetone (10 minutes). Following silanization, the
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probes were rinsed with deionized water and immersed in glutaraldehyde (0.5%, 30
minutes). The probes were then rinsed with deionized water and incubated in αvβ3
solution (100 μg/mL, 30 minutes). The probes were rinsed again and incubated in BSA
(100 μg/mL, 5 minutes) in order to block any remaining aldehyde groups. Probes were
stored at 4°C in phosphate buffered saline (PBS) and used within 48 hours.

2.5.3 AFM methods
For atomic force microscope (AFM) procedures in stiffness measurements of HEK293T
cell please refer to the relevant sections of [68].

For AFM procedures in unbinding event measurements of SS-RBCs please refer to the
relevant sections of [69].

2.5.4 Stiffness Curve Fitting Methods
Before curve-fitting is performed, each force-displacement curve is “flattened,” a process
in which the non-contact portion of the curve is set to have an average force response of
zero based on a linear regression in that portion of the curve. FRAME flattens the curve
in two steps. In the first step, it roughly guesses the contact point based on the location
of the relative decline in slope from the end of the approach curve (left side of the red
curve shown in Figure 2-1a). The search algorithm determines, starting from the leftmost
end, the point where the local slope of the approach curve is 𝑏 = 50% lower than the
slope at the leftmost end of the approach curve. We note that a value of 𝑏 between 10%
and 90% produces consistent final results (see Supplementary Figure 2-S1). FRAME
then applies a linear regression to the data from the start (rightmost end) of the approach
16

curve to this estimated point, and the curve is flattened based on the results of this linear
regression. In the second step, the resultant curve from the first step is used to obtain
bounds and initial conditions that are inserted in a least-squares-based curve-fit algorithm
to produce the final flattened curve as explained next.

Specifically, FRAME minimizes the following equation:

𝐹(𝑧) = 𝑓1 (𝑧) + 𝑓2 (𝑧) + 𝑓3 (𝑧)

𝑓1 (𝑧) = 𝑘1 𝑧 + 𝑘2

𝑓2 (𝑧) = 𝑔(𝑧 − 𝑧1 ) ∗ [𝐻(𝑧 − 𝑧1 ) − 𝐻(𝑧 − 𝑧2 )]

𝑓3 (𝑧) = [𝑘4 (𝑧 − 𝑧2 ) + 𝑔(𝑧2 − 𝑧1 )] ∗ [𝐻(𝑧 − 𝑧2 )],

where 𝑧 is the vertical displacement, 𝐹(𝑧) is force, 𝐻 is the Heaviside function, 𝑔(𝑧)
represents the contact model (Hertz rigid pyramid and Hertz spherical models are
included in FRAME)model, and 𝑘1 , 𝑘2 , 𝑘4 , 𝑧1 , and 𝑧2 are the design variables. In addition,
there is another design variable, 𝑘3 which is part of the contact model. Function 𝑓1 is
determined by the linear behavior of the force-displacement curve before contact.
Function 𝑓2 defines the contact model and its active domain. Finally function 𝑓3 is
determined by the curve behavior after the contact model range (beyond 𝑧2 ). The contact
model must be used in the flattening process because it affects the determination of the
non-contact domain where the curve must be flat. The contact point is defined as 𝑧1 , while
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𝑧2 defines the end of contact model domain. Users have the option of setting 𝑧2 to an
exact value relative to 𝑧1 or to set it as a design variable with defined bounds. The exact
expression of the function 𝑔(𝑧) depends on the geometry of the specific probe's tip. In
3 𝐸 tan(𝜃)
,
(1−𝑣 2 )

particular, for a rigid pyramid tip 𝑔(𝑧) = 𝑘3 𝑧 2 , where 𝑘3 = 4

𝐸 is the sample’s

Young’s modulus, 𝜃 is the angle between the sample and the side of the pyramid, and 𝑣
is the sample’s Poisson’s ratio. For a rigid spherical tip 𝑔(𝑧) = 𝑘3 𝑧 3/2 , where 𝑘3 =
4

𝐸

3 (1−𝑣 2 )

𝑅 0.5, 𝐸 is the sample’s Young’s modulus, 𝑣 is the sample’s Poisson’s ratio, and 𝑅

is the radius of the spherical tip. The contact point is defined as 𝑧1 , while 𝑧2 defines the
end of contact model domain. Users have the option of setting 𝑧2 to an exact value relative
to 𝑧1 or to set it as a design variable. To finalize flattening the function 𝑓1 (𝑧) is subtracted
from the curve. To obtain the contact point and the stiffness of the sample after flattening,
the minimization described above is repeated. We note that since flattening has already
been performed the value of the new 𝑘1 is approximately zero.
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Chapter 3: Atomic Force Microscopy in Single-Molecule Force
Spectroscopy and Single-Cell Force Spectroscopy
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3.1 Introduction
Although red blood cells (RBCs) are considered to be relatively inactive due to their lack
of a nucleus and organelles, they express surface adhesion receptors [17]. Many of these
receptors mediate cell-cell interactions, or adhesion, on healthy and pathological RBCs.
Knowledge of cytoadhesion is necessary to understand normal physiology, disease
pathophysiology, and cellular-level effects of pharmacotherapies. Atomic force
microscopy (AFM) [18] has introduced a wide range of approaches for measurements of
biological samples under physiological conditions [15, 19-27]. Here, we present singlecell force spectroscopy (SCFS) as a tool [28-31] for the quantitative study of RBC
adhesion while maintaining surface receptors in their native state. The technique is
performed by measuring the adhesion between a single RBC attached to an AFM
cantilever and a surface coated with purified proteins.
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AFM studies of RBC adhesion have been utilized to provide quantitative evidence of
changes in surface receptor distribution and values for unbinding forces with specific
ligands [15, 26]. A technique known as single-molecule force spectroscopy (SMFS)
measures the unbinding force, or detachment force, between a ligand on the AFM tip and
its corresponding receptor on the cell membrane with piconewton sensitivity [15, 22, 25,
27, 32-34]. SMFS operates by collecting a set of force-distance curves of the approachretract cycle between the functionalized tip and the cell surface. Specifically, the retraction
curve gives the detachment force. This technique allows for (i) quantifying the unbinding
force of specific receptor-ligand bonds, (ii) mapping the distribution and (iii) calculating
the density of active receptors on cellular surfaces with high resolution [35-39]. While
SMFS is a powerful technique to study RBC adhesion at the single-molecule level, it
cannot provide the overall adhesion of a cell to a substrate or to another cell. Further, it
is unknown how SMFS measurements compare to whole cell measurements.

To overcome these limitations, SCFS assays were developed [28-30, 40-42]. In SCFS, a
RBC attached to an AFM cantilever is positioned above a functionalized substrate or
another living cell. SCFS records force-distance curves of an approach/retract cycle
between the RBC probe and the functionalized substrate or cell. The RBC is lowered onto
the substrate/cell until a preset contact force is reached, and then held stationary for a
defined time. Subsequently, the cell is withdrawn at a constant speed and bonds between
the cell and substrate/cell break until separation. The detachment force is characterized
as the force required to fully disengage the RBC from the functionalized substrate. While
this in vitro assay can provide important details regarding RBC binding to laminin, it should
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be noted that in vivo RBCs may attach to a deformable layer of endothelial cells or interact
with other glycoproteins.

Here, we established the technique of SCFS as a method to probe RBC adhesion,
specifically with subendothelial laminin proteins. We found a correlation between SMFS
measurements and SCFS measurements. We also showed that SCFS can detect
significant changes in the adhesive response of RBCs to modulation of the cyclic
adenosine monophosphate (cAMP) pathway. Based on these measurements, we
identified variability in the RBC adhesion force to laminin amongst the human subjects,
suggesting that RBCs maintain diverse intracellular levels of tonic protein kinase A (PKA).

3.2 Methods
3.2.1 Human subjects, blood samples, and blood preparation
Healthy volunteers at least 18 years old were eligible to participate in this study if they did
not have a blood disorder or hemoglobinopathy, confirmed by screening blood samples
via complete blood count and hemoglobin electrophoresis. This study was approved by
the Institutional Review Boards of the UCONN Health Center and UCONN-Storrs.
Experiments were performed using fresh-drawn, heparin-anticoagulated venous blood.
Blood was centrifuged at 500g for 10min at 4°C to isolate the RBCs. The buffy coat and
plasma were aspirated and discarded. RBCs were then washed 3x with Alsever’s
solution.
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3.2.2 Reagents
Alsever’s solution, laminin, glutaraldehyde, biotinamido-caproyl-labeled bovine serum
albumin

(biotin-BSA),

streptavidin,

biotinylated-concanavalin

A

(ConA),

3-

aminopropyltriethoxysilane (APTES), forskolin (Coleus forskohli), KT-5720, epinephrine,
BSA, were purchased from Sigma Aldrich (St. Louis, MO). BCAM protein was obtained
from Novus Biologicals (Littleton, CO).

3.2.3 Surface coating with laminin
Glass petri dishes (Ted Pella, Redding, CA) were divided using a hydrophobic PAP pen
(Sigma Aldrich, St. Louis, MO) enabling us to separate RBCs from the laminin surface
(Figure 3-1a). Half of the glass surface was silanized with 2% APTES for 10min, rinsed
with deionized (DI) water, treated with 0.5% glutaraldehyde for 30min, rinsed, incubated
in laminin solution for 30min, rinsed, and incubated in BSA (100μg/mL) for 5min.

3.2.4 Cantilever preparation
Tipless silicon nitride AFM cantilevers (NanoWorld, Neuchâtel, Switzerland) were soaked
in acetone for 5min, UV irradiated for 15min, incubated overnight in 0.5mg/ml biotin-BSA
at 37°C, rinsed and treated with 1% glutaraldehyde for 30s, rinsed, incubated in 0.5mg/ml
streptavidin for 10min, rinsed, and incubated in 0.5mg/ml biotinylated Con A for 10min at
25°C.

Pyramid-tipped silicon nitride cantilevers (Bruker Probes, Camarillo, CA) for singlemolecule experiments were functionalized with BCAM protein as follows. Cantilevers
were silanized with 2% APTES for 10min, rinsed with DI water, immersed in 0.5%
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glutaraldehyde for 30min, rinsed, incubated in BCAM solution (100μg/mL) for 30min,
rinsed, and incubated in BSA (100μg/mL) for 5min.

3.2.5 Cell capture and experimental setup
Cells were allowed to bind weakly to the non-functionalized region of the glass substrate
via 10min incubation at 37°C followed by rinsing with Alsever’s solution, thus allowing for
cantilever engagement with a chosen RBC. Single cells were captured by positioning the
ConA-functionalized cantilever above the cell center (Figure 3-1a) and gently lowering
onto the cell for ~30s with a contact force of 1nN near the end of the probe (Figure 3-1c)
to prevent the cantilever surface from interacting with the laminin substrate. The cell was
lifted from the surface and allowed to establish firm adhesion to the cantilever before
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relocation to the laminin-functionalized region of the dish.

Figure 3-1 Measurement of red blood cell adhesion to subendothelial matrix laminin
using single-cell force spectroscopy. (a) The apex of a tipless ConA-functionalized AFM
cantilever is positioned above a RBC. It is then gently pushed (~1 nN) for 30s onto the
cell. The cantilever-bound RBC is separated from the substrate and allowed to establish
firm adhesion to the cantilever for 1 min. The cantilever is then slowly moved to the
functionalized segment of the petri dish to perform adhesion measurements. (b)
Representative force-distance curves obtained from experiments for an RBC probing a
laminin substrate. The measured detachment forces are 0.64nN in the first curve which
shows a single rupture and 1.06nN in the second curve which shows multiple rupture
events. (c) Optical microscopy image showing a human RBC attached to the apex of a
ConA-functionalized cantilever.
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3.2.6 AFM setup
Experiments were conducted using the MFP-3D-BIO AFM (Asylum Research, Santa
Barbara, CA) mounted on an inverted optical microscope (Zeiss Axiovert A1). For SCFS,
the nominal spring constant of the employed cantilever was 80mN/m. For SMFS, the
nominal spring constant of the employed cantilever was 30mN/m. The effective spring
constant was obtained via a thermal noise-based method and used in all calculations [43].
All experiments were performed in Alsever’s solution at 37°C, and biochemical
modulators were added 30min prior to experiments. For each assay, 5 RBCs were tested
from each subject’s blood. Values reporting “N=” denote the number of subjects per
condition and “n=” denote the total number of tested cells.

Each SMFS measuring session involved probing a 1µmx1µm region with a lateral
resolution of ~31.2nm. For substrate measurements, 3 areas of a functionalized substrate
were chosen at random and probed. For RBC measurements, one 1µmx1µm region was
recorded per RBC. Experiments were performed at a retraction speed of 800nm/s. Only
measurements with a single break between laminin on the cantilever tip and BCAM/Lu
on the laminin substrate or RBC surface were processed.

Each SCFS measuring session involved testing a single RBC probe attached to a
previously calibrated cantilever for 100 approach/retraction cycles on one section of a
laminin-functionalized glass substrate. As monitored by optical microscopy, the captured
cells rarely detached from the cantilever during pulling. Tests were performed with a
trigger force of 500pN with a contact time of 0.1s (unless noted), and the cantilever was
retracted at 800nm/s until the RBC completely detached from the laminin substrate.
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Force-distance curves were used to determine the detachment force of the RBC from the
substrate. A detachment force is defined as the maximum downward force associated
with the force-distance curve [28]. The median effective spring constant for the cantileverRBC-laminin adhesion complex was ~4.6pN/nm. We note that during the course of testing
each specific cell the median effective spring constant did not change, meaning that the
mechanical properties of the RBC membrane did not change during this experiment.
Representative curves are shown in Figure 3-1b. Further, while we could have also
computed the work of detachment [31], we preferred not to do so in order to properly
compare the SCFS measurements with SMFS measurements.

For both assays, we found that at 800nm/s hydrodynamic forces do not significantly affect
detachment

measurements

(Supplementary

Material).

We

considered

only

measurements for which the effective spring constant of the adhesion complex was less
than 10pN/nm with a median value of ~4.6pN/nm.

3.2.7 Statistical methods
Values for detachment forces are reported using box-and-whisker plots and frequency
distributions. In the frequency distributions reported for SCFS experiments, each bin
contains the number of detachment forces with values within the bin’s range divided by
the total number of approach/retraction cycles. For SMFS, frequency (%) is defined as
the total number of all non-zero force points divided by the total number of sampled sites
for each experimental condition.
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3.3 Results And Discussion
3.3.1 Surface density of laminin for functionalized substrates
To obtain the experimental parameters used in our SCFS assay, we first determined the
appropriate solution concentration of laminin to be used for substrate functionalization.
SMFS experiments were performed using a BCAM-functionalized probe against
substrates prepared with various solution concentrations of laminin (1µg/ml, 5µg/ml,
10µg/ml, 25µg/ml, 50µg/ml, 100µg/ml). For each substrate, 1024 measurements were
recorded in three different 1µmx1µm areas yielding a total of 3072 measurements for
each laminin solution concentration.

The detachment force of BCAM with laminin was nearly constant across all solution
concentrations (Figure 3-2b). Interestingly, this detachment force was larger than what
we previously measured for the inverse interaction between BCAM on the RBC and
laminin on the AFM probe using SMFS [15, 26]. We conjecture that more BCAM proteins
attached to the AFM tip make contact with multiple laminin proteins on the substrate since
we recorded multiple distinct rupture forces. A representative curve is shown in Figure 31b. BCAM proteins are approximately 6nm [44, 45], whereas laminin is a cruciform
structure with arms of lengths ranging between 40nm and 80nm [46]. Upon functionalizing
a substrate with BCAM and measuring the detachment force using a lamininfunctionalized probe, we confirmed that the median unbinding force is 41.4pN, in
agreement with previous measurements (Figure 3-2a).

28

Figure 3-2 Determination of laminin solution concentration to be employed in SCFS assay. (a)
Frequency distributions obtained from SMFS experiments of measured detachment forces
between (i) a substrate coated with laminin (50 µg/ml) and a BCAM/Lu probe, and (ii) a
substrate coated with BCAM (50 µg/ml) and a laminin probe. (b) Box-and-whisker plots of the
unbinding forces measured at each tested laminin solution concentration shows that the median
values are nearly consistent (0μg/ml: 66.1pN; 1 µg/ml: 182.2pN; 5 µg/ml: 225.0pN; 10 µg/ml:
185.3pN; 25 µg/ml: 144.8pN; 50 µg/ml: 138.9pN; Mann-Whitney test for 25μg/ml vs. 50 μg/ml).
(c) Plots of the substrate density measured at each tested laminin concentration shows that the
density appears to reach a plateau at 25 µg/ml (median values at 0 µg/ml: 1.63%; 1 µg/ml:
10.4%; 5 µg/ml: 4.3%; 10 µg/ml: 10.0%; 25 µg/ml: 7.8%; 50 µg/ml: 10.9%; Kruskal-Wallis oneway test for 10 μg/ml, 25 μg/ml, and 50 μg/ml). The median values and the respective ranges
are shown. (d) Frequency distributions obtained from SCFS experiments of detachment forces
between a RBC probe and laminin substrate (50 µg/ml) measured in the (i) absence and (ii)
presence of bath laminin. The significant reduction in the number of curves showing
detachment forces, from 66% to 12% (p<0.0001) demonstrates the specificity of the
measurements. (e) Box-and-whisker plots of detachment forces for human RBC probes (N=2,
n=10) at each laminin solution concentration. The median values of the detachment forces were
found to increase with higher laminin concentrations (0 µg/ml: 130.3pN; 1 µg/ml: 113.9pN; 5
µg/ml: 215.8pN; 10 µg/ml: 243.1pN; 25 µg/ml: 154.9pN; 50 µg/ml: 559.9pN; 100 µg/ml:
678.0pN), appearing to plateau at the 50 µg/ml concentration. (f) Plot of RBC binding frequency
shows an increase in binding as laminin substrate concentration increases (median values at 0
µg/ml: 16.5%; 1 µg/ml: 34.2%; 5 µg/ml: 43.0%; 10 µg/ml: 96.0%; 25 µg/ml: 46.6%; 50 µg/ml:
39.4%; 100 µg/ml: 72.4%). The median values and the respective ranges are shown.
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For laminin-functionalized substrates, the percentage of sampled sites where a
detachment force was detected, reflecting the density of laminin on the substrate,
increased with higher laminin concentrations (Figure 3-2c; hyperbolic fit). Variability
reflects different substrate and probe preparations. To determine background noise,
measurements were recorded on a substrate where the laminin-functionalization step
was omitted. Interactions were detected in 4.1±0.65% of sampled sites.

We next determined the effect of different laminin solution concentrations on the
adherence of RBC probes to laminin substrates. Background noise was quantified by
using a RBC to probe a substrate where the laminin-functionalization step was omitted.
Small forces with a median of ~130pN were detected in 16.5% of curves. The interaction
specificity was demonstrated by performing experiments in 100μg/mL bath laminin, thus
blocking BCAM/Lu receptors. By recording approach/retraction cycles between RBC
probes and a substrate functionalized with 50µg/ml laminin, the number of curves
showing detachment forces reduced from 66% to 12% (p<0.0001, Figure 3-2d) while the
median detachment force was ~112pN, similar to background noise. Further, detachment
forces recorded in bath laminin decreased five-fold, from a median value of 559pN to
106pN (p<0.0001) reflecting bath laminin bound to many BCAM/Lu receptors which
significantly reduced the propensity for binding of the RBC probe to the laminin substrate.

RBC probes were used to record forces against each laminin substrate. Detachment
forces were found to increase with higher laminin solution concentrations (p<0.0001),
appearing to stabilize around the 50µg/ml concentration (Figure 3-2e). For this
concentration, we obtained force curves characterized by median detachment forces up
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Figure 3-3 Human RBC adhesion to laminin
substrates (50 µg/ml) at increasing contact
times (N=2, n=10). Box-and-whisker plots show
that the detachment force for RBCs from
laminin substrates increase from 0.1s to 1s
contact time and then remains approximately
consistent. However, the range of measured
detachment forces increases. Median forces:
0.1s: 632.0nN; 1s: 952.9nN; 2.5s: 921.7nN; 5s:
1046.6nN; 10s: 999.8nN.

to 0.56nN. In contrast, lower concentrations resulted in median detachment forces of less
than 0.24nN, reflecting the need for a denser substrate laminin concentration to maximize
BCAM/Lu receptor binding. These detachment force values are comparable to those
observed for RBCs in other experiments [40]. Moreover, the frequency of RBC binding to
the laminin substrate also directly increased with laminin concentrations (Figure 3-2f;
p<0.0001).

From the experiments employed to determine the appropriate solution concentration of
laminin for substrate functionalization, we found that detachment forces appear to plateau
at the 50µg/ml laminin concentration (Figure 3-2e), whereas the surface density detected
via SMFS appears to plateau at ~10µg/ml (Figure 3-2c). Tethered polymer layers are
comprised of polymer molecules attached to a surface, with a density high enough to
cause the chains to stretch away from the surface [47, 48]. By maximizing the brush
height, the free-energy cost is minimized, thus minimizing inter-chain repulsion. This may
affect the binding of tested cells to proteins attached to a surface. The surface distribution
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of a tethered polymer layer can be characterized by the distance between attachment
points, 𝐷. As 𝐷 approaches the radius of gyration, 𝑅𝑔 , of the polymer chain, the molecules
interact and the polymer layer structure passes from the single-chain (mushroom) regime
to the brush regime. In the 'mushroom' regime the reduced tethered density, Σ = 𝜎𝜋𝑅𝑔2 ,
where 𝜎 = 1/𝐷2 , is Σ<1, the 'mushroom-to-brush' transition regime occurs for 1<Σ<5,
and the transition to 'brush' regime occurs at Σ=5. The value Σ=1 corresponds to 𝐷 =
𝐷2 = √𝜋𝑅𝑔 [49]. For the case of laminin, where 𝑅𝑔 ≅ 80 𝑛𝑚 [50, 51], the 'mushroom'
regime appears for 𝐷1 > 140 𝑛𝑚 and the transition to 'brush' regime occurs at 𝐷 = 𝐷2 =
𝐷1 ⁄√5 ≅ 63 𝑛𝑚. Because the lateral step size was ~31.2nm in SMFS experiments, after
the first transition point is reached, it is difficult to distinguish between different surface
densities. Based on Figure 3-2c, we conjecture that the first transition point, from
‘mushroom’ to ‘mushroom-to-brush’, was reached at the 10µg/ml laminin concentration.
This is reinforced by the fact that the binding frequency for SCFS experiments plateau at
the same laminin concentration, meaning that at this concentration, most of the substrate
is covered with laminin chains in the 'mushroom' form. We found however, that the
detachment force reached a plateau at ~50μg/ml solution concentration, meaning that the
binding between all active RBC adhesion receptors and laminin molecules reaches
equilibrium. We conjecture that this is the second transition point, from 'mushroom-tobrush' to 'brush' regime, and determined the corresponding concentration of 50μg/ml to
be most suitable for SCFS assays of human RBCs.
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3.3.2 Dependence of BCAM/Lu-mediated RBC adhesion on contact time
To investigate the time dependence of cell adhesion, we varied the contact time of RBCs
with 50µg/ml laminin substrates between 0.1s and 10s and determined the detachment
forces. For the 0.1s contact time, the median force required for RBC detachment from
laminin substrates was ~0.63nN. As the contact time increased to 1s, the median
detachment force increased to ~0.95nN. For contact times greater than 1s and up to 10s,
the median detachment force did not significantly change (Kruskal-Wallis test). We opted
to use the 0.1s contact time for experimental convenience because at higher time scales
the RBC had a greater probability of detachment from the probe prior to the completion
of 100 cycles resulting in experimental failure.

3.3.3 Increases in SCFS detachment forces correlates with increases in total
forces recorded by SMFS on 1 µm2 membrane regions
To determine the relationship between single-molecule and single-cell measurements,
we performed both assays using n=5 cells from human subjects (N=3). SMFS
experiments probed 1µmx1µm areas of the RBC surface with a lateral resolution of
~31.2nm, enabling us to measure single-rupture events. For the SCFS assay, RBCs
probed a laminin-functionalized substrate (50µg/ml laminin solution concentration) with a
contact time of 0.1s. For comparison of SMFS to SCFS, the resultant total force
associated with each 1µmx1µm membrane area was calculated as the product of the
frequency of detected events and the mean detachment force. For example, an area with
a mean detachment force of 39.51pN detected in 2.83% of sampled sites yields a total
force of 1.15nN. Resultant total forces ranged from 0.77nN to 3.92nN. In contrast,
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detachment forces obtained between single RBCs with a laminin substrate were lower,
ranging from 0.11nN to 1.8nN (Figure 3-4a). The mean detachment force for an entire
RBC corresponds to the simultaneous formation of ~20 active bonds between BCAM/Lu
proteins on the RBC surface and laminin on the substrate, calculated by dividing the
average single-cell detachment force by the average single-molecule detachment force.
The median detachment force of one BCAM/Lu receptor from laminin was found to be
40.62pN. We note that the SCFS technique reflects the overall RBC adhesion to the
substrate, whereas SMFS measurements represent direct ligand-receptor interactions.

Since multiple cells were tested from each subject, detachment forces could be compared
between subjects. The Pearson correlation test was used to determine the strength of
relationship between SMFS and SCFS assays (Figure 3-4b). We found that SMFS
resultant mean total force correlated strongly with the mean detachment force obtained
via SCFS (r=0.99, R2=0.99). Due to the fact that SCFS measurements reflect currently
active bonds, as well as innate cellular features, they can be used as an innovative tool
to study RBC adhesion. However, it is important to note that detachment of the cell from
the substrate is a complicated process, and the detachment force obtained is a result not
only of receptor-ligand binding strength and spatial distribution of receptors on the cell
membrane but also of other factors such as membrane fluctuations, cellular elasticity, and
cell shape [28, 52, 53]. RBC deformability plays a significant role in SCFS measurements,
whereas SMFS measurements represent direct ligand-receptor interactions. Increases in
RBC compliance may allow the cell to spread, leading to an increased number of ligandreceptor interactions and in effect, greater detachment forces measured via SCFS [42].
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Figure 3-4. Correlation of single-cell measurements with traditional SMFS
measurements. (a) Box-and-whisker plot of the detachment forces from SMFS and
SCFS assays. Experiments were performed on 5 cells from each human sample (N=3).
SCFS experiments used single RBCs to probe a laminin functionalized substrate
(50µg/ml) with a contact time of 0.1s. SMFS experiments probed BCAM/Lu receptors
on 1 µm x 1 µm areas of the RBC surface with a laminin-functionalized probe. The
resultant total force for each area was calculated as the product of the frequency of
detected events and the mean detachment force. (b) Correlation of the mean resultant
total force on 1 µm x 1 µm areas of the RBC surface obtained via SMFS with the mean
detachment force obtained via SCFS measurements (Pearson correlation test; r=0.99,
R2=0.99). Each plotted point represents 5 tested cells from one healthy subject.

3.3.4 cAMP-dependent modulation of red blood cell adhesion to laminin via
BCAM/Lu
To establish the sensitivity of the assay in the adhesion of BCAM/Lu to laminin, we
investigated changes in the detachment force of single RBCs with laminin via
pharmacologic modulation of the cAMP-signaling pathway. Previous experimental
approaches utilizing flow adhesion assays have shown that the interaction between
BCAM/Lu and laminin is mediated by cAMP-dependent PKA [54]. Stimulation of the β235

adrenergic receptor (β2-AR) [55, 56] activates the G-protein coupled receptor Gαs, which
stimulates adenylyl cyclase (AC) [57]. AC catalyzes the conversion of adenosine
triphosphate (ATP) to cAMP, resulting in PKA activation and ensuing BCAM/Lu-laminin
adhesion. In human RBCs, basal cAMP levels are controlled through the activity of
phosphodiesterases [58, 59], which limit the signaling lifespan of cAMP and the distance
it can diffuse from its production site [60].

RBCs were treated with forskolin (30μM, FSK), a strong AC activator. Compared to
untreated RBCs, forskolin-treated RBCs exhibited significantly higher detachment forces
(Figure 3-5a,b,e; p<0.0001, Mann-Whitney U test). To quantify the effect of direct PKA
inhibition on the RBC detachment force from laminin, RBCs were treated with KT-5720
(1μM), a PKA inhibitor, which resulted in a significant decrease in detachment forces from
baseline (Figure 3-5c; p<0.0001). Based on these results, we conjecture that RBCs
maintain varying intracellular levels of tonic PKA [60, 61]. We speculate that this tonic
PKA is modulated by cAMP levels and must be raised for the activation of BCAM/Lu
receptors to occur, resulting in elevated adhesion to subendothelial laminin. The reduction
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Figure 3-5. Single-cell force spectroscopy can clearly detect significant changes in
RBC adhesion to laminin substrates (50µg/ml) following treatment with biochemical
agents modulating the cAMP-dependent pathway. (a) Frequency distribution of the
detachment forces associated with healthy RBCs at baseline (N=3, n=15) shows a
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median force of 594.2pN . (b) Measurement in FSK (30 µM) indicates a significant shift
of the recorded detachment forces (p<0.0001, Mann-Whitney U test) and an increase
in the median detachment force to 837.9pN . (c) Measurement in KT-5720 (1 µM)
indicates a significant shift of the detachment forces (p<0.0001) and a decrease in the
median detachment force to 148.3pN. (d) The physiologic implication of cAMPstimulated adhesion was studied. Measurement in epinephrine (1 µM) indicates a
significant shift of the detachment forces (p<0.0001) and an increase in the median
detachment force to 825.8pN. (e) Box-and-whisker plots of detachment forces obtained
for healthy RBCs from laminin substrates in the presence and absence of biochemical
agents known to modulate cAMP-dependent adhesion; (*) indicates p<0.0001 and (**)
indicates p<0.016.
in the number of active BCAM/Lu receptors on the RBC surface following inhibition of
PKA activity with KT-5720, reflected by the significant decrease in detachment forces, is

suggestive of a tonic drive. Even in the absence of PKA inhibitors and activators, PKA
exerts a sustained, steady-state activation of BCAM/Lu receptors. Finally, the physiologic
implication of cAMP-stimulated adhesion was studied by treating RBCs with epinephrine
(1μM), a hormone which stimulates the β2-AR. This resulted in a significant increase in
the detachment forces compared to baseline (Figure 3-5d; p<0.0001). These data
demonstrate that the single-cell AFM assay can detect differences in the detachment of
whole RBCs from a laminin substrate in response to pharmacologic modulation (Figure
3-5e).

3.4 Conclusion
SCFS was established as a method to quantify the strength and modulation of adhesion
of human RBCs to functionalized substrates. Using SMFS and SCFS, we determined the
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appropriate solution concentration of laminin to utilize for substrate functionalization via
the density of protein adsorption to the substrate. From these tests, we determined the
50µg/ml solution concentration of laminin to be most effective. Then, we probed laminin
substrates with RBCs using contact times ranging from 0.1s to 10s. We chose 0.1s
because of the low potential for experimental failure prior to the completion of 100
approach/retract cycles and for comparison between single-molecule and single-cell
measurements. We found a significant correlation between results from SMFS
measurements probing BCAM/Lu with a laminin-functionalized probe and SCFS
measurements probing a laminin substrate with an RBC probe. Finally, we established
that SCFS can detect variations in the detachment force of RBCs to laminin based
primarily on the number of active BCAM/Lu receptors, which was modulated via
biochemicals affecting the cAMP-PKA pathway. This study shows important implications
for AFM-based SCFS measurements in understanding and evaluating the pharmacologic
response of adhesion receptors on RBCs.
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Chapter 4: Red Blood Cell Specific Adhesion and Mechanical
Properties in Microfluidics
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4.1 Introduction
Sickle cell disease (SCD) is a genetically inherited disorder characterized by painful vasoocclusive crises in which blood flow to parts of the body is obstructed [1]. Vaso-occlusion
is the result of interactions between blood cells and the endothelium [2-4]. It has been
shown that the adhesive behavior and viscoelastic response of SS-RBCs are important
factors in vaso-occlusion [8]. SS-RBC adhesion to specific proteins, such as human
integrin 𝛼𝑣 𝛽3, expressed on the endothelium has been implicated as part of the
mechanism that triggers vaso-occlusive crises [9, 10]. During a vaso-occlusive crisis
adherent SS-RBCs in the vasculature obstruct other SS-RBCs due to their viscoelastic
and mechanical properties [13, 14].

A number of experimental tools have been used to quantify SS-RBC adhesion to proteins
expressed on the endothelium. To this end, atomic force microscopy (AFM) has been
employed in single-molecule force spectroscopy (SMFM) and single-cell force
spectroscopy (SCFS) assays [10, 15, 16]. These assays offer insight into molecular level
interactions, but only a few RBCs can be tested this way under each condition. In contrast,
perfusion chambers and microfluidic devices have been utilized with the same aims [11,
70]. These setups provide the potential for concurrent high-throughput assays that are
more clinically relevant than AFM-based techniques. However, current microfluidic
assays face many design challenges in terms of functionalization and flow control.
Specifically, physical adsorption of targeted proteins directly on the microchannel
surfaces has become a staple of microfluidic assays due to the ease of application and
because of the difficultly in utilizing other strategies when microchannels are assembled
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using oxidative sealing [71]. Unfortunately, this functionalization technique produces
weak and unstable immobilization bonds between the proteins and the substrate. In
addition, proteins do not bind specifically, orient themselves randomly, and are capable
of forming as many bonds as they have binding sites [72]. This can lead to experimental
protocols that are marred by background RBC adhesion to the substrate itself and
adhesion to protein binding sites that are not of interest to the specific study. On the other
hand, the use of volumetric flow pumps in microfluidic assays prevents instant changes
in flow parameters, thus severely limiting options in assay design.

The mechanical properties of wildtype RBCs have been explored both empirically and in
simulations [73-75]. As such, optical tweezers and micro-pipettes have also been
employed to study SS-RBC viscoelastic properties [8, 76]. Also, the mechanical
properties of SS-RBCs have been investigated using AFM [77]. Because these assays
feature direct manipulation of individual SS-RBCs they are time consuming, have low
throughput, and contain generalizations and potential errors arising from the type and
shape of the device. Tangentially, a microfluidic assay enabled by a custom made
pressure driven flow has been used to study viscoelastic properties of sickle cell trait
RBCs [78].

In this work, we propose a microfluidic approach that addresses the complications found
in adhesion assays by using a functionalization strategy in which a known protein binding
site covalently bonds with the substrate in order to create a uniformly dense functionalized
surface. In order to facilitate the functionalization, the microchannel is assembled through
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aspiration, which keeps the functionalized areas inside of the microchannel untouched
[79].

In concert with this design, a pressure controlled pump allows us to introduce a wellcontrolled flow inside the microchannel. The use of a pressure pump allows us to quantify
SS-RBC adhesion to a functionalized substrate not only by the fraction of remaining
adherent RBCs at the end of each experiment but also by their ability to withstand wall
shear stress increases during experiments. This feature empowers us to quantify the
mechanical properties of SS-RBCs by instantly modulating the flow while tracking the
morphological changes in SS-RBCs that have adhered directly to a glass substrate.

4.2 Materials and Methods
4.2.1 Equipment
Precise and steady control of microfluidic flow was achieved with a pressure controller
(OB1 Microfluidic Flow Control System; Elveflow, Paris, France). Both the inlet and outlet
ports of the microfluidic device were independently controlled by the pressure controller
in order to increase precision. The microchannel was observed and recorded digitally by
an Orca-Flash 2.8 high speed camera (Hamamatsu Photonics K.K.; Hamamatsu City,
Japan) attached to an Olympus IX73 inverted microscope (Olympus Corporation;
Shinjuku, Tokyo, Japan). A diagram of the setup is shown in Figure 4-1A. In adhesion
experiments a 20x magnification objective lens, numerical aperture (NA) of 0.45, was
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Figure 4-1 A. Graphic showcase of the experimental equipment. B. A computer-aided
design rendering of the polydimethylsiloxane component of the microfluidic assembly
exhibiting the aspiration network around the microchannel. C. A processed background
image of a video recorded during an RBC to endothelial protein adhesion assay where
individual adherent RBCs are identified. The paths of non-adherent RBCs can be made
out as blurs.
used, while recovery experiments utilized a 40x magnification objective lens, NA of 0.6.
The high speed camera captured 45 frames a second. A custom LabVIEW user interface
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was used to control both devices digitally and record pressure readings and video footage
simultaneously.

4.2.2 Microchannel fabrication
Polydimethylsiloxane (PDMS) microchannels were created using photolithography to give
all features a height of approximately 32 m . The master mold was created following
standardized permanent epoxy negative photoresist processing guidelines provided by
MicroChem (USA; Westborough, MA). To summarize briefly, the master mold was
created by covering a 100 mm diameter silicon wafer with SU-8 2025 negative
photoresist, spin coated to achieve the desired feature height, covered with the mask of
the design, and exposed to ultraviolet (UV) light in order to crosslink the polymer. The
relief structure was then developed using 1-Methoxy-2-propyl acetate (SU-8 developer)
and covered with PDMS prepolymer, which was then cured to create the PDMS
elastomer. The PDMS microchannels were cut from the wafer and peeled off from the
master mold. The microchannel device featured a 15 mm long and 1 mm wide
microchannel, connected at either end to 6 mm diameter antechamber wells. The size of
the wells was necessary to promote structural stability of the microchannel.

The microfluidic device was attached, through aspiration, to a functionalized glass slide
substrate (See Figure 4-1B) [79]. This method of assembly allows substrates to be
functionalized before the device is assembled since the functionalization is not altered or
destroyed during assembly, as in oxidative sealing. Truncated and polished 20 gauge
needles were employed as the inlet and outlet ports of the microchannel, and were
connected to 6 mm diameter antechamber wells of the microfluidic device. The aspiration
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network was connected by a 2mm diameter tygon tube to a vacuum pump that supplied
a negative pressure of 75 kPA. The microchannel was brought into contact with the
functionalized glass slide substrate while submerged in phosphate buffered saline (PBS),
in order to prevent the formation of an air bubble inside the microchannel.

4.2.3 Functionalization
Human integrin 𝛼𝑣 𝛽3 (EMD Millipore; Billerica, MA, USA) was covalently bound to an Nhydroxysuccinimide (NHS) functionalized glass slide (NHS surfaces; MicroSurfaces, Inc.,
Englewood, NJ, USA) in order to facilitate a uniform coating [72]. In order to bind the
protein, it was deposited onto the slide at a concentration of 270

𝑚𝑔
𝑚𝐿

in Triton-X 100 and

incubated on the slide for 20 minutes at 37°C. The excess solution was then rinsed off
the slide with PBS, the slide was coated with a proprietary buffer solution (MicroSurfaces,
Inc., Englewood, NJ, USA) to remove unbound NHS groups and incubated for 30 minutes
at room temperature to this end. The excess buffer solution was rinsed off the slide with
PBS. The functionalized slide was then stored in PBS and immediately used.

4.2.4 Sample Preparation
This study was approved by the Institutional Review Boards of the UCONN Health Center
and UCONN-Storrs. Volunteers with SCD, at least 18 years of age, were eligible to
participate in this study. RBCs from consented volunteers were separated from freshly
drawn, heparin-anticoagulated, venous blood by centrifuge, at a relative centrifugal force
of 500g for 10 minutes at 4° C. Afterward, the buffy white coat and plasma were removed
by aspiration, and the RBCs were washed three times with Alsever’s solution, a saline
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solution used to store blood [80]. RBCs were diluted down to a hematocrit of 0.5% for the
adhesion assay and 1% for the viscoelasticity assay in Alsever’s solution before being
introduced into the microchannel. This hematocrit was selected in order to maximize the
acquisition of useful images during video recording, such that there were as many nonoverlapping RBCs in each frame as possible.

Epinephrine was added to the SS-RBC solution to produce a final concentration of
16.4 𝑛𝑀. The SS-RBCs solution with Epinephrine was incubated for 30 minutes before
the experiment was conducted. Propranolol was added to the SS-RBC to produce a final
concentration of 10 𝜇𝑀. The SS-RBC solution with propranolol was incubated for 30
minutes before the experiment was conducted.

4.2.5 Adhesion Assay
SS-RBCs from one concenting patient in Alsever’s Solution (Sigma-Aldrich, St. Louis,
MO, USA) at a 0.5% hematocrit were introduced into the microchannel and allowed to
adhere to the functionalized substrate for 10 minutes at a pressure drop that produced a
0.1

𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2

wall shear stress. After this initial period, all RBCs in a 3 𝑚𝑚2 area inside the

microchannel were recorded. The pressure drop across the microchannel was then
increased to produce 1, 5, 10, 20, and 30

𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2

wall shear stress and the adherent RBCs

were recorded in the same 3 𝑚𝑚2 area 1 minute after each increase. After all wall shear
stresses measurements were taken, the microchannel was discarded.
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4.2.6 Viscoelasticity Assay
Untreated, baseline, SS-RBCs from one concenting patient, in Alsever’s Solution at a 1%
hematocrit were introduced into the microchannel and allowed to adhere to the glass
substrate for 10 minutes with no pressure drop across the microchannel. The recoveries
of adherent SS-RBCs due to the instant change in wall shear stress from 1
(physiological wall shear stress) to 0

𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2

𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2

were recorded.

4.2.7 Data Processing
A custom MATLAB script was used to detect and quantify adherent RBCs. A background
image of each recorded video was created by averaging all individual pixel values over
all frames. This filtering method obfuscates all moving objects and retains all stationary
ones in the background image. The background was then cropped to the area of interest,
devignetted, and sharpened using unsharp masking. The edges of all RBCs were
quantified by the Canny edge detection algorithm. The convex hulls of all object edges
were then labelled, and sorted based on size: objects smaller than a potential RBC
(smaller than 4 𝜇𝑚 in diameter) were discarded while objects larger than a potential RBC
(larger than 12 𝜇𝑚 in diameter) were broken up into multiple objects using the watershed
algorithm. The final set of objects were again sorted by size such that objects too small
(smaller than 4 𝜇𝑚 in diameter) or too large to be an RBC (larger than 12 𝜇𝑚 in diameter)
were discarded. The remaining objects were counted and overlaid on the original image,
so that the computed result could be double checked and adjusted manually to ensure its
accuracy (see Supplmentary Figure 4-S1).
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In viscoelastic experiments, RBCs were identified on a frame by frame basis after the
frames were cropped, sharpened, and devignetting. Each individual RBC was identified
and tracked throughout a video. The tracking was automated using a custom MATLAB
code, and the results were verified manually and corrected where necessary. RBC
morphology was determined by fitting the identified shape of the RBC with an ellipse.
Only adherent yet freely deformable and mobile RBCs were selected, manually, for
processing (see Supplmentary Figure 4-S2 for an example of SS-RBC morphology at
different applied wall shear stresses).

Though these simple MATLAB codes have been highly customized for our use and are
of little scientific interest in and of themselves, we have made them available online
(http://www.engr.uconn.edu/%7Egelyko/additionalsoftware.html) as an example of the
exact processing logic, algorithms, and working parameters we used.

4.3 Results and Discussion
4.3.1 Adhesion Assay
One patient’s SS-RBC’s affinity to adhere to a 𝛼𝑣 𝛽3 functionalized substrate was
modulated by epinephrine, an agonist, which has been shown to increase SS-RBC
adhesion to the endothelial protein [9]. Epinephrine produces this effect by upregulating
cAMP in RBCs and stimulating protein kinase A, which increases SS-RBC adhesion [2].
Consistent with previous findings, the adherent population of SS-RBCs treated with
epinephrine was not only greater but resisted higher wall shear stresses than SS-RBCs
not treated with epinephrine (See Figure 4-2). Additionally, we predict that antagonists,
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such as propranolol, may not only block the action of agonists, but actively reduce SSRBC adhesion to a 𝛼𝑣 𝛽3 functionalized substrate. Consistent with this conjecture, we
found that the adherent population of SS-RBCs treated with propranolol was lower and
could not withstand wall shear stresses as high as that of untreated SS-RBCs (see Figure
4-2).

Figure 4-2. Adherent populations of
untreated SS-RBCs alongside those
treated with epinephrine and propranolol
relative to their respective initial adherent
populations to a substrate coated with
human integrin 𝛼𝑣 𝛽3 at increasing wall
shear stresses. When treated with
epinephrine, SS-RBCs adhere in greater
relative numbers at larger stress than
when untreated. SS-RBCs treated with
propranolol appear to adhere in fewer
relative numbers than untreated SSRBCs. Due to the large number of initial
SS-RBCs (n>300 for each data point), the
95% confidence intervals of each data
point, if displayed, would be obscured
entirely by the symbols representing the
measured values.

Each measurement is based on a minimum of 300 initially adherent RBCs spread
uniformly over a 3 𝑚𝑚2 area. Background adhesion, evaluated with a slide coated only
with the background PEG layer, was found to be negligible below a shear stress of 5

𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2

and non-existent above (data not shown). Thus, we are quantifying, almost exclusively,
SS-RBC adhesion to human integrin 𝛼𝑣 𝛽3. By incrementally increasing wall shear stress
on the group of adherent SS-RBCs and recording each change, we are able to
50

meaningfully measure the strength of adhesion of SS-RBCs to the specific receptor 𝛼𝑣 𝛽3
with high throughput. Due to this uniformity and the large number of processed cells, we
expect that the reported values are true for the entire sample and that this precision will
remain consistent in future patient samples. As with AFM measurements, we expect to
observe large variability between samples drawn from different patients and even
samples drawn from the same patient on different dates. However, when we treated the
patient sample with epinephrine and propranolol the modulation of the adhesion was in
agreement with the expected trend that we have previously reported based on AFM. We
expect that using the proposed method we will be able to measure the same modulation
in future patient samples.

We note that the adhesion levels of individual RBCs from the same sample are diferent
from cell to cell. This has been observed in whole RBC adhesion experiments where the
adhesion force between a RBC and a functionalized substrate was measured via AFM
[16] and in single molecule force spectroscopy experiments where the expression of
active adhesion receptors was measured [15, 81]. Because of this, we expect that the
same level of wall shear stress will not have the same effect on all RBCs in terms of
detachment from the substrate. Nonetheless, we observed that higher wall shear stress
results in a lower adherent fraction and after a sufficiently high value almost, depending
on the RBC adhesion level, all RBCs are detached.

4.3.2 Continuous Flow and RBC Elongation
Based on the pressure pump’s internal pressure sensors, which record pressure drop
experienced across the microchannel every 0.1 seconds, we have found that the
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Figure 4-3A. The extension ratio of an adherent red blood cell (RBC) follows the
oscillating wall shear stress applied on it closely, demonstrating that the measured
pressure drop across the microchannel as well as the RBC morphology are accurately
tracked. B. The major and minor axes of an RBC as it undergoes recovery from a wall
𝑑𝑦𝑛𝑒
shear stress of 7 𝑐𝑚2 near the 2 second mark. The RBC recovery is curve-fit to the
solution of the Kelvin-Voigt model in which no external forces are present. C-D. Box
plots of the measured shear modulus and viscosity of adherent SS-RBCs (𝑛 = 21) as
𝑑𝑦𝑛𝑒
they recovered from 1 𝑐𝑚2 wall shear stress. The notches on the box-plots represent
the 95% confidence intervals of the measured medians.
response time of our microfluidic system is 0.1 seconds at the slowest. Observations of
RBC morphology suggest that the system responds even faster and clearly indicate that
continuous input pressure changes are experienced across the microchannel
corresponding to continuous pressure changes. We have verified this by applying an
oscillating pressure drop across the channel and simultaneously measuring the major and
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minor axes lengths of an adherent RBC and evaluating its elongation index as 𝐸𝐼 =
𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠 − 𝑚𝑖𝑛𝑜𝑟 𝑎𝑥𝑖𝑠
𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠 + 𝑚𝑖𝑛𝑜𝑟 𝑎𝑥𝑖𝑠

(see Figure 4-3A).

4.3.3 SS-RBC Recovery
The viscoelastic properties of the SS-RBC membrane were quantified by measuring the
shear modulus and viscosity using the Kelvin-Voigt model for a Neo-Hookean near
incompressible material with linear viscous response:

𝑇𝑠 1 2
𝜕 ln(𝜆)
= (𝜆 − 𝜆−2 ) + 𝑡𝑐
,
2𝜇 4
𝜕𝑡

𝜂

where 𝜇 is the membrane shear modulus, 𝑡𝑐 ≡ 𝜇 is the characteristic time, 𝜂 is the
𝑑𝑒𝑓𝑜𝑟𝑚𝑒𝑑 𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠 𝑅𝐵𝐶 𝑙𝑒𝑛𝑔𝑡ℎ

membrane viscosity, 𝜆 = 𝑢𝑛𝑑𝑒𝑓𝑜𝑟𝑚𝑒𝑑 𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠 𝑅𝐵𝐶 𝑙𝑒𝑛𝑔𝑡ℎ is the extension ratio, and 𝑇𝑠 =
𝑇1 −𝑇2

𝜏 ∗ 𝑑𝑒𝑓𝑜𝑟𝑚 𝑅𝐵𝐶 𝑎𝑟𝑒𝑎

is the membrane shear stress where 𝑇1 = 𝑑𝑒𝑓𝑜𝑟𝑚𝑒𝑑 𝑅𝐵𝐶 𝑚𝑖𝑛𝑜𝑟 𝑙𝑒𝑛𝑔𝑡ℎ and 𝑇2 = 0 are the

2

in-plane principal membrane stresses, and 𝜏 is the wall shear stress applied on the RBC
2𝑇

[75, 82]. The shear modulus was obtained via the expression 𝜇 = (𝜆2 −𝜆−2 ), where 𝜆 is the
extension ratio between two steady-state conditions. The viscosity was evaluated as 𝜂 =
𝜇 ∗ 𝑡𝑐 where 𝑡𝑐 was found by curve fitting the relaxation data of the instantaneous
Λ + exp(−𝑡/𝑡 )

extension ratio 𝜆(𝑡) with the analytical solution 𝜆(𝑡) = √Λ − exp(−𝑡/𝑡𝑐) of the governing
𝑐

equation for zero applied membrane forces (see Figure 4-3B), where 𝑡 is the time, Λ =
𝜆2𝑚 +1

, and 𝜆𝑚 is the extension ratio at the instance when the applied membrane forces are

𝜆2𝑚 −1

set to zero.
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The viscosities and shear moduli of SS-RBCs were measured using this method as
shown in Figure 4-3C and 4-3D. The measured shear moduli are of the same order of
magnitude, though nominally higher, as those reported by [82]. This is consistent with our
expectations, since the aforementioned work investigated wild type RBCs and previous
efforts from our lab have measured higher Young’s Moduli in SS-RBCs with respect to
their wild type RBC counterparts [83]. The time constant, 𝑡𝑐 , was found to be on the same
order of magnitude as the original findings by [75], signifying that the reported viscosity
measurements are in agreement with both works. The width of the 95% confidence of the
shear modulus measurements (~2

𝜇𝑁
𝑚

) is a product of the large number of processed

RBCs, and we expect future processed samples to continue to produce measurements
of comparable precision.

4.3.4 Conclusion
The implemented experimental setup presents an opportunity to quickly and precisely
quantify the mechanical and pharmacological properties of SS-RBCs in many different
assays. This is enabled by the combination of equipment, specifically the high-speed
camera and the precise and instantly modifiable pressure flow, the surface
functionalization protocol, and custom image processing software. Minor tweaks to the
assay parameters, such

as the

concentration of

endothelial protein

during

functionalization, may also be appropriate to maximize the sensitivity of the system and
elucidate SS-RBC properties. The current setup can be easily modified to enable
experiments under controlled oxygen levels.
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These experimental methods may potentially also be conducted in similar assays on
wildtype RBCs or in efforts to study other related diseases, such as malaria or diabetes,
where either RBC adhesion or mechanical behavior plays a major role in pathology. The
same advantages and improvements presented in this report may prove to be applicable
is such studies. Thus, this potential is an avenue for future work in this area.

Acknowledgements
We thank Ms. Kaylee Perron for her assistance in processing and acquiring preliminary
recovery data and her input in improving portions of the video processing code.

Funding
This work was supported by the Connecticut Institute for Clinical and Translational
Science (CICATS) at the University of Connecticut. The content is the sole responsibility
of the authors and does not necessarily represent the official views of CICATS. GL is
supported by the National Science Foundation (CMMI-1235025, PHY-1205910), the
American Heart Association (12SDG12050688), and UCONN Academic Plan II.

55

4.4 Supplementary Information

Supplementary Figure 4-S1. The intermediate outputs of the custom video data
processing MATLAB script used to detect and quantify adherent RBCs. A. A typical
frame of a recorded video. B. The background of the video. Note that only adherent
RBCs can remain in the image. C. The devignetted, cropped background. D. Output of
the Canny edge detection algorithm on the processed background. E. The convex hull
regions of all edges. F. Independent regions are identified, labelled, approximated by
an ellipse, processed based on size (rejected or split), and finally the approximated
ellipses are overlaid over the devignetted and cropped video background. The user
adjusts program count by accounting for missed or lumped cells as well as falsepositive identification of objects other than SS-RBCs.
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Supplementary Figure 4-S2. The approximated morphology of a SS-RBC, denoted
𝑑𝑦𝑛𝑒𝑠
𝑑𝑦𝑛𝑒𝑠
cell 2, that has been deformed at A 7 𝑐𝑚2 wall shear stress, B 5 𝑐𝑚2 wall shear
stress, and C 0

𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2

wall shear stress.
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Chapter 5: Assembly for Measuring the Viscosity of Fluids Using
Microchannels
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5.1 Introduction
The viscosity of nearly all liquid products, whether consumer, industrial, or medical in
nature, must be ascertained during both formulation and quality assurance. The viscosity
of body fluids, such as whole blood and blood plasma has been shown to be a powerful
tool in cardiovascular health evaluation and in monitoring several diseases. For instance,
non-medical rheology measurements are important in both the development and the
quality assurance of inks[113], paints[114], petroleum[115], cosmetic products[116, 117],
oils[118], coatings[119], adhesives[120], consumer care products[121], extrusion
polymers[122],

foods

and

beverages[116,

117,

123],

and

pharmaceutical

formulations[117, 124].

Both viscometers and rheometers suffer from numerous drawbacks. Most notably, such
devices require a significant amount of sample liquid, typically a full vial. This requirement
often makes such instruments unfeasible in applications where the sample is expensive,
such as in bioprinting inks. Rheometers are also typically heavy and require peripheral
equipment to operate. This immobility prevents technicians from bringing the device to
the sample. Constant cleaning is necessary between the measurement of every sample.
The measurement process itself can be very slow. One sample can take half an hour or
more to process. Such a long processing time may exclude samples which undergo a
change, such as adhesives, inks, and epoxies. Many affordable models also necessitate
the need for a trained technician with an engineering background and a familiarity with
the theoretical expressions exploited by their device. Without double checking the
measurement data, these instruments may produce results that are 10 or 100 times off
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from reality. The price of trained personnel combined with the long measurement times
can costs companies significant sums. Instruments which fix most of these issues are
orders of magnitude more expensive than their counterparts.

Due to the technological challenges involved, body fluid viscosity measurements such as
whole blood viscosity (WBV) and blood plasma viscosity have not been a prevalent
medical measurement despite evidence of their value in cardiovascular risk management
and in evaluating cognitive ability in Alzheimer’s Disease. High WBV measurements have
been strongly correlated with cardiovascular events, such as stroke and ischemic heart
disease. A 1996 study measured the WBV of more than 1,500 people and followed up
with them 5 years later in order to identify any cardiovascular events. The investigators
found WBV to be a powerful long term predictor of cardiovascular events, stronger even
than conventional risk factors such as LDL cholesterol, smoking, or diastolic blood
pressure [125]. A recently published study that followed more than 3,000 subjects over
the course of approximately 17 years found similar results for both WBV and plasma
viscosity [126]. A number of other studies have reported comparable findings [127, 128].
An affordable point-of-care rheometer may also be of particular useful in Alzheimer’s
Disease evaluation. WBV has been found to be correlated with cognitive ability and can
be used as a biomarker in monitoring the disease

[129, 130]. In Waldenström’s

Macroglobulinemia (WM), which is a type of cancer that causes hyperviscosity syndrome
(HVS), a condition in which the viscosity of blood is too high, oncologists actively need to
monitor their patients’ blood plasma viscosity [131]. Other disease which produce the risk
of HBS include multiple myeloma [132], paraproteinemia [133], and polycythemia [134].
Blood viscosity measurements may also be useful in monitoring risk of leg ulceration and
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possibly vaso-occlusive episodes in sickle cell disease [135]. We further hypothesize that
a small sample body fluid rheometer may also be of consequence in dialysis, diabetes
monitoring, as well as in sports medicine.

5.2 Final Product
We are have designed a small-sample microfluidics-based rheometer that will provide
viscosity results over a continuous range of shear rates in at most 5 minutes. Our device
will not require peripheral equipment to operate and will also be portable. The device itself
consists of two parts: the core device that conducts and records the measurements and
a refillable microchannel cartridge that is the only component which comes in contact with
any liquid sample. This is particularly useful for certain liquids, such as inks, adhesives,
epoxies, and especially in body fluids because the device will not need regular cleaning
or sterilization between uses. Furthermore, the cartridges will be tagged with an RFID
chip that will provide important information to the core device in order to improve the
fidelity of the measurement and ensure that only our cartridges can be used with the core
device. Thanks to the nature of microchannels, the rheometer will only require a small
volume of the sample liquid for a viscosity measurement. We anticipate that 500 𝜇𝐿 of a
sample will be necessary at most per measurement. For WBV measurements, medical
practitioners will only need to administer a finger prick to their patients in order to acquire
enough blood for a complete measurement and a full blood draw procedure will not be
necessary. In bioprinting inks the use of this device will produce significant savings by
reducing the waste of expensive sample. The device will also be able to measure plasma
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viscosity, an already established laboratory measurement, as well as any low viscosity
body fluids and industrial liquids.

To perform the measurement, our rheometer will continuously record the position of a
liquid sample as it traverses a microchannel. This information can be used in combination
with the microchannel dimensions to determine the sample viscosity at a continuous
range of shear rates. The shear rate range can be controlled by the microchannel
dimensions. The sample will traverse the microchannel from end to end by means of
capillary pressure, which must be quantified during each measurement. If the
measurement of capillary pressure is
not reliable enough for our customers
or does not provide them with sufficient
measurement options, samples will be
made to traverse the microchannel by
means

of

a

controlled

negative

pressure. This addition, however, will
still require a measurement of capillary
Figure 5-1 A mock-up of the final device with an
inserted cartridge.

pressure

because

to

it

is

non-

negligible. The measurement of liquid
viscosity based on the detection of the

position of the interface and its speed in a microchannel was established by Srivastava
et al [1]. The biggest challenge for the automation of this method is the detection of the
sample location. The answer to this challenge has typically been the digital image
processing of captured video. However, this technique is computationally demanding
64

because the traveling interface of the sample must be established through digital image
processing of every video frame. This method requires the use of a computer powerful
enough to quickly process the necessary video processing algorithms. Our device meets
this challenge in tracking and processing the sample through the microchannel by
exploiting the increase of the absorption and scattering of light that illuminates the channel
as the sample flow progresses through it. Essentially, a bright collimated light is emitted
above the microchannel and is recorded by a photodiode below it. As the sample enters
and traverses the microchannel less and less light can reach the photodiode due to the
shadow the sample casts. The signal from the photodiode can processed to find the exact
positions of the sample column along the microchannel with respect to time and then
establish the flow speed. A mockup of what the final device may look like can be seen in
Figure 5-1. A diagram displaying the physical principles used by the sensor is presented
in Figure 5-2.

5.3 Technical Discussion
We can quantify liquid viscosity by recording the position and velocity of a liquid column
as it is introduced to and traverses a microchannel open on both sides to atmospheric
pressure. We measure the position of the liquid column through a single photodiode
receptor, essentially a 1-pixel camera (Figure 5-2). In order to track and record the
process, we first record how much collimated light passes through an empty
microchannel. As a liquid enters and begins to traverse the microchannel it obscures the
light source from the photodiode and we continuously record the drop in the voltage
across the photodiode. Once the liquid has traveled the entire length of the microchannel
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the voltage levels out and the cartridge can be removed from the device. The recorded
voltage signal can then be converted directly to liquid column length. To do so we first
normalize the signal by the final and initial voltage levels and then we multiply the length
of the microchannel cartridge by 1 minus the signal. The resultant signal is the position of
the liquid column over time and its numerical derivate with respect to time produces the
average liquid velocity (or volumetric flow rate if multiplied by the cross-sectional area of
the microchannel). We have validated the exactness and repeatability of this
measurement technique in several experiments (one example in Figure 5-3). The
quantification of viscosity itself is discussed in detail in Power Law Index section.

Figure 5-2 Rhoemeter design and physical principle: the position of the liquid column is
identified by the shadow it casts on a photodiode.
This technique has a number of critical advantages. First of all, the simplicity of the core
devices means that the final product can be made durable, reliable, and portable while
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still being affordable. Furthermore, because
the signal is normalized during the signal
processing, there is no need to calibrate the
photodiode sensor or the light source. Even if
the liquid is partially transparent, if some
significant amount of light is blocked the
device will function correctly. There is also no
need to account for temperature variance
effecting the power of the light source so long
Figure 5-3 Single photodiode liquid
column detection method agrees with as it is not happening in the middle of the
digital image processing
measurement. It also means that the
microchannel itself does not need to have any micro-electro-mechanical system
components in order to conduct the measurement. Therefore, the final microchannel
cartridge can be extremely affordable to mass produce. The main drawback of this
technique is the inability to detect liquids that are too transparent. To accommodate such
liquids, we are currently developing a version of the device with dark-field microscopy
principles which we have already validated will allow a single photodiode to detect
transparent liquid traversal in a laboratory setting.

5.3.1 Capillary Pressure inside the Microchannel Cartridge
The pressure applied on the liquid column is one of several factors necessary to properly
evaluate the viscosity of the travelling liquid, though it is the only one that cannot be
evaluated before the measurement. The full viscosity measurement is very sensitive to
changes in this pressure and this pressure must thus be accurately quantified during
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every single viscosity measurement. We have chosen to use capillary pressure as the
driving force of the measurement because it greatly reduces system complexity and
removes the need to install, calibrate, and validate a pressure pump. Furthermore,
capillary pressure quantification would be necessary even in the presence of a pressure
pump since a non-negligible capillary effect would still be present in low viscosity liquids.
The Young-Laplace equation describes mathematically the pressure experienced by the
liquid (Δ𝑃) in terms of the liquid surface tension (𝜎), radius of curvature of the liquid
surface inside the microchannel (𝑅1 ) and the radius of curvature of curvature of the droplet
outside the microchannel (𝑅2 ) as

Δ𝑃 = 𝜎(

1
1
+ )
𝑅1 𝑅2

This expression [136] may simplify for certain liquids and particularly large droplets to
Δ𝑃 = 𝜎 / 𝑅1 in the case that 𝑅2 ≫ 𝑅1 . The capillary pressure can be further expressed in
terms of the contact angle 𝜃, the microchannel height 𝑑, and the microchannel width 𝑤
1

1

as 𝑃𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑦 = 2𝜎 cos(𝜃) (𝑑 + 𝑤) [137]. Since 𝑑 ≪ 𝑤 in a typical microchannel, this
expression can be simplified to

Δ𝑃 =

2𝜎 cos(𝜃)
𝑑

However, the surface and contact angle are specific to every liquid sample. It is not only
impractical to measure both of these values before conducting a viscosity measurement
but introduces further potential sources of error into the final capillary pressure
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measurement. Instead, capillary pressure must be measured during the experiment and,
because in some measurements 𝑅2 might still play an effect and change during the
measurement, it must be measured and recorded continuously throughout the
experiment. We note here that based on preliminary analysis other forces, such as the
hydrostatic force of the liquid droplet, are negligible.

Capillary Pressure itself can be measured through several techniques. For instance, the
sample droplet can be exposed to a secondary microchannel of the same dimensions
which is closed on the far end. As the sample enters and begins to traverse the
microchannel, it will begin to compress the air inside. Eventually, the pressure of the
compressed air will equal the capillary pressure and will stop the sample from moving
forward. This air pressure, which equals the capillary pressure (𝑃𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑦 ) can be
measured with a pressure sensor or by relating the new volume the air encompasses
(𝑉𝑛𝑒𝑤 ) in the microchannel to the original microchannel volume (𝑉𝑜𝑟𝑔 ) with relation to the
atmospheric pressure (𝑃𝑎𝑡𝑚 ) such that 𝑃𝑎𝑡𝑚 𝑉𝑜𝑟𝑔 = (𝑃𝑎𝑡𝑚 + Δ𝑃)(𝑉𝑛𝑒𝑤 ) that is

Δ𝑃 = 𝑃𝑎𝑡𝑚

𝑉𝑜𝑟𝑔
− 𝑃𝑎𝑡𝑚
𝑉𝑛𝑒𝑤

Alternatively, the main channel can be blocked off with a valve, after the air has
pressurized and a value is reached, the valve can be opened to continue the experiment.
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5.3.2 The Power Law Index
The principle of quantifying fluid viscosity based on microchannel traversal was described
by Srivastava et al. in 2005 for Newtonian liquids [138] and 2006 for Non-Newtonian
liquids [139]. For non-Newtonian liquids, the aforementioned method used a HagenPoiseuille flow equation modified to conform to a Power Law Fluid. Power Law Fluids are
idealized models used to describe real liquids. The expressions the authors developed
are

1
= 𝐶𝑣(𝑡)𝑛
𝐿(𝑡)

𝜂(𝑡) =

𝑑2
1
Δ𝑃
𝑆 (2 + 1 ) 𝑣(𝑡)𝐿(𝑡)
3 3𝑛

Where 𝑛 is the power law index which describes the change in viscosity with respect to
shear rate, 𝐿(𝑡) is the liquid column length, 𝑣(𝑡) is the liquid column mean velocity (which
is directly proportional with volumetric flow rate), 𝜂(𝑡) is the viscosity, 𝑑 is the thickness
of the microchannel, 𝑆 is a constant factor characterizing the geometry, 𝐶 is a constant
dependent on the power law index, and Δ𝑃 is the pressure applied on the microchannel.
As expected, this expression simplifies to the Hagen-Poiseuille flow equation when 𝑛 =
1, which is a Newtonian liquid described by the power law. If the power law index 𝑛 is
constant, it is possible to curve-fit the first expression in order to quantify 𝑛.
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We note here that a constant value of 𝑛 does not describe many liquids correctly. Applying
the aforementioned expression directly and conforming to the assumption that 𝑛 is
constant can produce erroneous viscosity results. Based on preliminary data we have
found the value of the power law index depends on shear rate. Future work may develop
an algorithm to identify the values of 𝑛 of the liquid continuously throughout the
measurement.

However, in the cases that the power law exponent 𝑛 is, in fact, constant, the expression
1
𝐿(𝑡)

= 𝐶𝑣(𝑡)𝑛 is an ordinary differential equation which may be solved as

𝐿(𝑡) = [(𝑡 + 𝑡0 ) (

𝑛
1 𝑛+1
𝑛

𝑛+1 1
)( ) ]
𝑛
𝐶

Where 𝑡0 is a constant that is 𝑡0 = 0 if the measurement begins at 𝑡 = 0. This expression
can be curve-fit to the data of the liquid column length with respect to time to find the
value of 𝑛.

5.3.3 Shear-Rate Range
The Shear-Rate applied to the liquid is dependent on how far into the channel it has
pervaded. The wall shear rate can be evaluated as

𝛾̇𝑤 =

6𝑄(𝑡) 2 1
[ + ]
𝑤𝑑2 3 3𝑛
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Where 𝑄(𝑡) is the volumetric flow rate and the other parameters are as described in the
Power Law Index section [139]. We note that the Hagen-Poiseuille flow equation is known
to fail in particularly short pipes due to the molecular limitations in liquids that are not
accounted for in the equation. In our case this is analogous to a sample first entering the
microchannel.

Figure 5-4 A Early prototype featuring core device components B. Microfluidic cartridges
comprised of glass and specialized hydrophilic microfluidic polyester films. C. Preliminary
viscosity data of black ink (top) and shoe shine (bottom).

5.4 Results
We have created a preliminary stationary prototype using premanufactured components
in order to demonstrate the feasibility of the sensor. This device (Figure 5-4) has
demonstrated the feasibility of tracking liquid traversal through a microchannel. The
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prototype features the vital working components that will comprise the final core device.
Using this $1,500 prototype, we have collected preliminary viscosity measurements of a
black ink and a shoe shine and corroborated the measurements using a $70,000
industrial rheometer (AR G2 Magnetic Bearing Rheometer by TA Instruments). These
preliminary measurements were done by estimating capillary pressure, manually
managing the curve-fit of the data to find the power law index of the liquid sample, and
manually eliminating the potentially erroneous shear rate range of the measurement. This
prototype was created in order to minimize the time required to collect meaningful result
using the physical principles we wish to exploit. A number of parameters still need to be
accounted for with greater fidelity using additional sensors, most notably the exact value
of the capillary pressure must be recorded with greater precision. Future work may also
include the application of dark field microscopy principles to the set up in order to
accurately track transparent liquids.

Our microfluidic cartridges are comprised of two constantly hydrophilic microchannels.
The cartridge is comprised of a glass slide, a central polyester layer which has been cut
to the dimensions of a desired microchannel, and a transparent polyester layer of which
has been laser cut to provide inlet and outlet ports for the device and give a hydrophilic
coating. None of the three materials are air permeable, which is an important factor in
several potential techniques of determining the capillary pressure experienced by the
liquid. Both of the polyester films already have FDA approval and a number of medical
conversion companies use them to mass produce microfluidic devices.
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We have developed a functional circuit
board outfitted with a photodiode, a
pressure sensor, and external input
and output to communicate with a
personal commuter (Figure 5-5). The
circuit board records the amount of
light collected by the photodiode and
Figure 5-5 Printed circuit board for our next
the pressure experienced by the
prototype design and experimental setup.
pressure sensor and streams the
information through a USB connection at up to 10,000 Hz. The streamed data is
processed by MATLAB and LabView codes to convert the results into viscosity
measurements. This circuit board may be integrated into a second portable version of the
prototype in Future Work. The second prototype will act as the main tool in the
development of solutions for the associated technological challenges of quantifying the
capillary pressure, the sample’s power law index, and the working shear rate range.

Figure 5-6 Viscosity measurements for
the same sample (black ink) are
consistent, varying approximately 20%.
This results assumes a consistent
capillary pressure, a consistent manual
selection of an appropriate constant factor
characterizing the microchannel, and
assumes that the power law exponent is
constant. The appropriate shear rate
range was also manually selected and
results at either extreme were discard.
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Chapter 6: Simulation and Visualization in Virtual Reality
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equally to final product. While Dr. Ha and I have contributed to all parts of the final product,
Dr. Ha’s efforts focused on the original IMPETUS code itself in order to facilitate its
integration with virtual reality and to enable runtime interactivity in IMPETUS. My work
focused on visualization of simulations, the user experience, interactivity, and the
interface between simulations and the Unreal Engine 4. I also designed and implemented
the code and method for the visualization of three-dimensional data. Kyle Blummer and
Daniel Balla provided investigatory support into methods and shaped early version of the
code. Prof. Lykotrafitis administered and supervised the project and edited this
manuscript.

6.1 Introduction
Intuition, conjecture, and experimentation are essential driving forces behind innovation
and scientific discovery. These principles may be intrinsically augmented thanks to the
appearance of immersive virtual reality in the public eye. The success of this tool
invariably forces us to inquire into the fundamental nature of how we perceive and interact
with the world around us. Within this framework, interactive simulations in a virtual reality
(VR) environment border on becoming virtual experiments conducted by the researcher.
Interactive simulation has already been used in surgical simulations to train medical
professionals in place of cadavers or animals [84, 85], to assist and save cost in parts
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design [86], and even in flood threat analysis [87]. Furthermore, the development of any
one simulation benefits directly from a design philosophy that integrates constant
visualization and interactivity [88]. The use of contemporary virtual reality enables swift
and intuitive detection of errors and conflicts between simulation parameters and reality.

Virtual reality in general has enjoyed an enthusiastic academic and commercial
community of developers for a number of decades. Numerous attempts at immersion in
a virtual world have been explored with varying degrees of success in that time. The early
1990’s saw a rise in public interest in VR with the developments of a number of VR
systems such as the CAVE system [89], a cubic room of screens meant to immerse
multiple users, though the system suffered from its cumbersome size and high price-tag,
PowerWalls and its derivatives [90], arrays of screens or very large screens such as the
ImmersaDesk and Inifinity Wall, and commercial attempts at releasing low resolution
head-mounted displays (HMDs). These tools were studied for their effectiveness in
various applications, such as the delivery of exposure therapy, though the associated
technological challenges proved too cumbersome for the time [91].

Despite public focus leaving VR, development and enhancement of the technology
continued steadily. Over the last five years, HMDs have breached public discourse on a
massive scale once again thanks to technological advancements that provide
unprecedented visual fidelity packaged with affordability. These advancements include
high-refresh rate, high resolution, and low-persistence displays, fast and accurate motion
tracking, and personal computers capable of continuously rendering graphically
impressive virtual worlds. As a result of this high visual fidelity, the best modern HMDs
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(e.g. HTC Vive, Oculus Rift) provide users with a superior sense of presence, a selfreported quality of “being there” [92]. Modern HMDs, which became available for
application development in 2013 and to the public commercially in 2016, have
experienced relative commercial success in entertainment and, concurrently, a number
of VR-centric studies have reported success in a varied assortment of clinical applications
[91, 93-97]. Modern HMDs provide the academic community at large the opportunity to
utilize VR in applications that were previously unattainable. The standardized interface
code that is now employed commercially ensures that VR applications will remain
compatible with upcoming HMDs.

One simulation technique that can considerably benefit from integration with modern
HMDs is molecular dynamics (MD). Virtual reality provides an immersive experience that
can bestow a deep intuitive understanding of the molecular interactions and their effect
on the emergent system. Without the use of modern HMDs such an intuitive
understanding of MD simulations is challenging to acquire even with the aid of
contemporary visualization tools, such as VMD [98]. Interactivity with simulations during
run-time is certainly possible in programs such as VMD but the associated screen-based
interfaces, traditional input controllers (e.g. mouse and keyboard), and classical VR
systems often complicate three-dimensional interactions and exploration to the point of
impracticality. Integration of MD with modern HMDs will allow researchers to intuitively
perturb and interact with their simulations in VR by applying external forces, steering
components, and by causing shape changes.
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Visualization of volumetric images, as those produced by techniques such as confocal
microscopy, super-resolution microscopy [99], magnetic resonance imaging, and cryoelectron microscopy [100] has long suffered due to the underlying complication of having
to display innately three-dimensional images on incompatible two-dimensional monitors.
Even three dimensional anaglyph stereoscopy is used in order to ease the difficult
interpretation of volumetric data [101, 102]. Similar to its application in MD in this regard,
virtual reality offers a natural and compatible way to reconstruct and explore volumetric
images and simulations by invoking them in a three-dimensional environment. A number
of academic and commercial packages, such as UCSF ChimeraX [103] and VMD,
currently provide shape rendering in both classic and contemporary VR systems, and
integration with classic VR systems has been available since their inception. These tools
use algorithms that attempt to display a solid shape meant to represent the scanned
object, commonly referred to as an “iso-surface.” However, such algorithms may
significantly distort particular volumetric maps, especially those that display gradients,
subtle effects, or “soft boundaries.” Sculptor [104], a notable open-source visualization
package, provides users with a direct volume rendering technique in order to render
gradients or “soft boundaries” [105] and even integrates with classic VR systems.
However, the software is not currently directly compatible with modern HMDs.

The recent technological breakthroughs in HMD technology in the last five years have
paved the way for us to undertake these challenges to integrate the visual fidelity, coding
standards, and affordability of modern HMDs with (1) manual and immersive threedimensional particle steering during simulation run-time and with (2) undistorted
volumetric rendering of static volumetric maps such as those produced by confocal
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microscopy. We have developed an interactive multiphysics simulation and visualization
environment in virtual reality called Interactive MultiPhysics EnvironmenT for Unified
Simulation in Virtual Reality (IMPETUS-VR). Using this tool, researchers will be able to
experience and manually interact with their simulations and steer individual components
during runtime. IMPETUS-VR offers researchers interactive VR integrated particle-based
simulations that interact with and run in parallel with gradient continuum field simulations
and long-range force network simulations. Additionally, they will be able to literally walk
through the data and explore any static volumetric image (defined by cross-sectional
volumetric maps) in the very same three-dimensions inherent in their image while
maintaining the integrity of the image. The fundamental dimensional agreement between
the simulation or image space and the visualization space grants ineffable understanding
of the simulation or image details and allows the researcher to exert immediate control
over their work. The dimensional agreement also allows researchers to not only instantly
select any desired perspective, including inside the simulation itself, but to observe and
interact with previously unobservable blind spots that could not be accessed through twodimensional representations.

6.2 Design and Implementation
Simulations in IMPETUS-VR are powered by the Interactive MultiPhysics EnvironmenT
for Unified Simulation (IMPETUS) [106] which is a powerful C++ based, object oriented
simulation engine. IMPETUS is capable of simultaneous and interdependent evaluation
of continuum models, long-range particle networks, and short-range particle interactions.
This code is available independently, with associated tutorials, online. All IMPETUS
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functionality has been fully implemented in IMPETUS-VR. Thus, users can create and
visualize simulations using the IMPETUS libraries, or even import molecular dynamics
configurational files, such as .cfg, in order to view them in virtual reality. They can also
employ the code structure that we have provided with IMPETUS-VR, which is based on
Unreal Engine 4, as a foundation for implementing their preferred MD simulation code.
The demonstration video of IMPETUS-VR (Supplementary Video 1) illustrates the general
functional principles of the software and some of its practical applications.

6.2.1 Code Structure
This environment was made possible by integrating a serialized version of the Interactive
Multi-Physics EnvironmenT for Unified Simulations (IMPETUS) [106] with the Unreal
Engine 4. We chose Unreal Engine 4 because it offers openly available source code. In
IMPETUS-VR the Unreal Engine 4 software is responsible for the interactivity and the
visualization of the simulation state: the software renders the state and handles user
interactions and commands. In turn, IMPETUS processes the simulation in a separate
thread, a technique known as multithreading, which functions on the principle of
evaluating multiple processes concurrently. This means that as each visualization frame
is rendered for display any spare computational power is allocated to the numerical
computation of the simulation. The structure of the code can be seen in Figure 6-1.
Throughout the course of simulation development in virtual reality, we have found that an
inconsistent or jarring frame rate is difficult to observe at best and nauseating at worst.
Multithreading empowers IMPETUS-VR to maintain an adequate visualization frame rate
at the cost of potentially slowing down the computation time of particularly large
simulations.
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Figure 6-1. IMPETUS-VR connects the Modular Interactive Domains (MIDs) of
IMPETUS to the Unreal Engine. These domains are currently the Particle Dynamics
domain, Interactive Finite Difference domain and the Network domain. Unreal Engine
4 renders and presents the scene to the user through the HTC Vive. The Vive
controllers allow users to directly interact with and influence the simulations.

6.2.2 Volumetric Visualization Algorithm
We implemented the visualization of volumetric three-dimensional microscopy images
following a heuristic approach where every cross-section of the image is displayed as an
individual image separated in the normal direction from adjacent cross-sections. Each
slice is partially transparent such that the transparency of every pixel is linearly inversely
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proportional to its brightness. The method is demonstrated in Figure 6-2. This
implementation of volumetric representation produces little computational overhead
without sacrificing the fidelity of the source image. Volume rendering algorithms that also

Figure 6-2. Algorithm for volumetric representation of a 3D confocal microscopy image
via IMPETUS-VR. (A,B) The fluorescent channel of the z-stack of the images recorded
through a confocal microscope (A) are combined to produce a full-color image for each
slice (Bii). B(i-iii) are sampled slices in the z-stack generated as explained above. (C)
These slices are then loaded in IMPETUS-VR in an ordered manner and made partially
transparent on a pixel-by-pixel basis such that dark pixels are more transparent than
bright pixels. (D)The individual images are then placed in a three-dimensional space on
top of one another and presented to the viewer as a full volumetric image.

84

preserve image integrity, such as volume ray casting or three-dimensional texturing, are
too computationally taxing, and thus preclude the use of modern HMDs. Conversely,
algorithms, such as the shear warp algorithm [107]

or splatting [108], which are

sufficiently inexpensive to render in virtual reality degrade image quality and often
misrepresent the acquired data. This is due to the algorithm’s core goal to represent the
volumetric object as a solid shape with a well-defined boundary. The conversion from
volumetric map to solid object may significantly distort the original cross-sectional
volumetric maps especially when gradients, subtle effects, or “soft boundaries” are
present in the map. These and similar algorithms are currently the most popular methods
of volumetric visualization of the majority of modern VR applications.

6.2.3 Computer Specifications
IMPETUS-VR was tested with the HTC Vive on a custom built computer running Windows
10 (Intel® Core™ i7-5820K CPU @ 3.30GHz, Radeon RX480 graphics card, 16GB of
RAM, and MSI X99A Raider motherboard) and visualized more than 15,000 individual
low polygon count spheres or more than 65,000 individual cubes without a frame rate
drop in virtual reality. The number of seamlessly rendered simulation components is a
hardware limitation that will improve with the release of superior hardware.

6.3 Ethics Statement
The individual in this manuscript (Supplementary Video 1) has given written informed
consent to publish these case details.
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6.4 Results
In order to highlight the capabilities of IMPETUS-VR we have produced a number of fully
interactive simulations that users may modify by using a personal virtual reality head
mounted display and associated controllers. Specifically, we have developed a solventfree model of a phospholipid bilayer (Figure 6-3A, Supplementary Vid. 2) [109], and a
simulation of a spectrin network which corresponds to the cytoskeleton connected to the
red blood cell membrane (Figure 6-3B) [110]. The specific models are discussed in detail
in [109] and [110] respectively. These simulations demonstrate the ability to explore
interactively the properties of emergent systems as they are perturbed and rearranged in
virtual reality. Furthermore, using IMPETUS-VR, we modeled the interaction between
cranial neural crest and cranial placode cells during collective cell migration
(Supplementary Figure 6-2A, Supplementary Vid 3) to reproduce experimental results
produced in Theveneau, E. et al. [111]. This simulation is an example of a continuum field
whose gradient is visualized as green vectors with orientations and magnitudes that are
explicitly apparent in virtual reality. This clarity is not practically achievable outside of the
realm of VR. We have further produced an exemplary simulation of a network of particles
that interact via long-range spring forces while at the same time are subjected to the
Lennard-Jones potential and to the Nose-Hoover thermostat (Supplementary Figure 62B, Supplementary Vid 4). This simulation demonstrates the visualization of long-range
forces as “tethers” within virtual reality. We note that these simulations are described in
greater detail in their original non-interactive non-VR states in the IMPETUS publication
[106]. Similar manual particle steering during simulation run-time applications have
historically been available in classic VR systems, such as VMD. However, these tools
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lack integration with modern HMDs and are generally meant as two-dimensional “onscreen” applications. As a result, their practical usability suffers in terms of affordability
and three-dimensional freedom of movement, especially when manual steering and view
selection requires the use of mouse and keyboard, which physically restrict user inputs
to two dimensions.

Figure 6-3. Exemplary simulations provided with IMPETUS-VR. A. A simulation of a
solvent-free model of a phospholipid bilayer where each blue shape represents a
cluster of lipids, while the red and yellow shapes represent arbitrary membrane
proteins. B. A spectrin network which corresponds to the cytoskeleton connected to the
red blood cell membrane. The red particles represent actin junctions and the green
particles represent spectrin chain repeats.
We note here that we have developed a number of user controls meant to improve the
user experience. We implemented simple “floating menus” in order to allow users to
navigate the software while using the HMD itself. These menus are inspired by similar
menu options seen in modern VR entertainment applications. Our experience with the
IMPETUS-VR environment has shown that floating menus, which make the use of
keyboard and mouse unnecessary, greatly improve practical usability of the virtual
environment as well as suggest enhancement of the sensation of presence (the selfreported quality of “being there”). Another feature developed with the user in mind are the
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exploration controls which we designed to minimize the potential for “virtual reality
sickness” (also known as “cyber sickness” or simply “motion sickness”) [112]. In
IMPETUS-VR, users directly control the rotation and position of the visualized object
itself, rather than their own virtual position. These controls are intended to promote a
sense of control over the visualized object while maintaining the stability of the viewer in
the virtual world.

To further showcase the abilities of IMPETUS-VR in terms of volumetric visualization, we
have provided a number of volumetrically rendered confocal microscopy images. A 102
µm by 102 µm by 19 µm confocal microscopy image of a kidney mouse section can be
seen in IMPETUS-VR (Figure 6-5A, Supplementary Vid 5). The three-dimensional
structure of the mouse kidney section can be partially inferred in the figure itself, however
it is self-evident when viewed in three dimensions. We have also included a confocal scan
of ICAM4 expressed on the surface of a Sickle Red Blood Cell (Figure 6-4). We note that
the integrity and clarity of gradients and subtle effects visible in the individual crosssections of the volumetric maps remain observable in final volumetric render. However,
this particular method prevents users from changing image channel representations (i.e.
individual colors meant to identify different components of the volumetric map) in realtime due to the way each individual cross-section is represented. This is a fundamental
limitation of the technique itself, and although a menu and tools can be added to allow
users to adjust channel intensities in real-time the response would likely be too slow using
modern personal computers to be considered practical. Another limitation comes from the
fact that the render is not comprehensible when viewed exactly from the side, where the
individual layers appear to have no thickness. We note that these limitations can be
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overcome with the use of certain established direct volume rendering techniques, such
as those used by Sculptor [105], though these and similar algorithms may be too
computationally taxing for high resolution volumetric maps to be used in current HMDs.

The preceding figures and others are available as 360 panoramas and can be viewed
online through your browser, cell phone, or personal virtual reality headset
(http://www.engr.uconn.edu/~gelyko/impetusvr.html). We have also made the program
code (under the GNU General Public License version 3) and associated libraries, the
demonstration video, a user manual, and a tutorial video available online at the same web
address.
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Figure 6-4 Volumetric representation of a three-dimensional confocal microscopy
image of a sickle-cell red blood cell (SS-RBC). The green color represents ICAM4
receptors expressed on the surface of a red blood cell while the red color represents
𝛼𝑣 𝛽3 protein that is adherent to the SS-RBC surface. Data courtesy of Dr. Krithika
Abiraman, reproduced here with her permission.
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Figure 6-5. Volumetric representations of three-dimensional confocal microscopy
images. A. A 102 μm x 102 µm x 19 µm volumetric image of a kidney mouse section.
Here the blue color represents actin, the green color represents wheat germ agglutinin
(a general stain for the surfaces of cells), and the red color represents the nuclei. B. A
290 µm x 290 µm x 20 µm scan of a hippocampus section where the red color
represents cell nuclei stained with DAPI and the green color represents activated glial
cells stained with GFAP.
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6.5 Supplementary Information

Supplementary Figure 6-S1. An IMPETUS-VR render of exemplary simulations. A.
The interaction between cranial neural crests (represented by blue particles) and cranial
placode cells (represented by red particles) during collective cell migration as it viewed
by the user inside the head mounted display. The green arrows represent the threedimensional gradient field of the chemoattractant produced by the placode cells. The
nature of the gradient field is clearly apparent in virtual reality. B. A simulation
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highlighting the representation of the network of long-range particle interactions
displayed as red “tethers.”
Supplementary Videos 1 through 5 can be found online at
http://www.engr.uconn.edu/~gelyko/impetusvr.html
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Chapter 7: Epilogue
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We have worked to expedite the acquisition of results, whether simulation or
experimental, and to increase the throughput of measurements in studies which utilize
atomic force microscopy, explore cell adhesion to specific proteins, in simulations which
explore cell mechanics, and in rheological measurements. Overall we have explored
several techniques to accomplish this, namely automated data processing, virtual reality,
and microfluidics. These methods provide the possibility of accelerating the acquisition of
sound experimental and simulation data.

Data analysis of force spectroscopy curves from atomic force microscopy has historically
been a very time-consuming and tedious endeavor. Researchers can spend several
hours processing the results from just several. To alleviate this massive time waste we
developed FRAME. Our software offers a directly applicable array of modifiable tools to
AFM users for expediting data processing. FRAME algorithms process AFM data
extremely quickly compared to the time required for manual processing. 1024 curves are
processed in less than one minute for unbinding events and in less than five minutes for
Young's modulus measurements in a typical work station. FRAME also provides
convenient manual processing tools that are integrated with automated processing.
FRAME can automatically import force-displacement curves from AFMs by Asylum
Research (.ibw files). Users of other brands of AFMs can import force-displacement
measurements formatted as delimited text files into FRAME following instructions in the
User's Manual.

Early versions of FRAME developed out of our exploration of Single Cell Force
Spectroscopy where the need for increased processing speed was readily apparent. We
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used the original functions and GUI-free environment to established SCFS as a method
in quantifying the adhesion of RBCs to functionalized substrates. This method allowed us
to explore the modulation of RBC adhesion via physiological reagents, such as
epinephrine, by affecting the cAMP-PKA pathway.

We needed to explore the adhesive and mechanical properties of a larger number of
RBCs at one time because the data may be too variable for 5 cells to describe the
properties of the population in a meaningful way. To meet this need, we produced a highthroughput microfluidics testing setup. This experimental setup presents an opportunity
to quickly and precisely quantify the mechanical and pharmacological properties of SSRBCs in many different assays. This is enabled by the combination of equipment,
specifically the high-speed camera and the precise and instantly modifiable pressure flow,
the surface functionalization protocol, and custom image processing software. Minor
tweaks to the assay parameters, such as the concentration of endothelial protein during
functionalization, may also be appropriate to maximize the sensitivity of the system and
elucidate SS-RBC properties. The current setup can be easily modified to enable
experiments under controlled oxygen levels.

The experimental methods above may potentially also be conducted in similar assays on
wildtype RBCs or in efforts to study other related diseases, such as malaria or diabetes,
where either RBC adhesion or mechanical behavior plays a major role in pathology. The
same advantages and improvements presented in this report may prove to be applicable
is such studies. Thus, this potential is an avenue for future work in this area.

97

Current solutions for measuring whole blood viscosity are not practical for the application:
tests are slow, require a lot of blood and sterilization, and the associated equipment is
complex and not portable. We have endeavored to enable simple and accessible whole
blood viscosity measurements by designing and developing our own microfluidics based
rheometer. Our assembly for measuring the viscosity of various liquids through the use
of microchannels provides a promising improvement in currently available rheometers.
Several key features, such as fast measurements, small sample size, and lack of
sterilization may produce a device which enables regular whole blood viscosity
measurements even at the point of care. This measurement is important in hyperviscosity
syndrome, a condition which may arise in certain illnesses such as Waldenström’s
Macroglobulinemia. Whole blood viscosity may also be important in monitoring overall
cardiovascular health.

We have produced IMPETUS-VR to create truly interactive three-dimensional simulations
and an intuitive three-dimensional data visualization environment. This tool greatly
improves the fidelity, development, and understanding of IMPETUS simulations.
Furthermore, it provides researchers a method of visualizing their three-dimensional data
in three-dimensions, instead of distorting it into two-dimensions.
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